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Abstract 
There are currently a few bioinformatics tools, such as dbEST, DDD and GEPIS to 
name a few, which have been widely used to retrieve and analyse EST data for gene 
expression levels.  The Cancer Genome Anatomy Project (CGAP, run by NCBI) cDNA 
xProfiler and cDNA DGED tools can be used to examine EST to compare gene 
expression levels between cancer and normal tissue.  However, neither CGAP nor other 
similar tools provide an easy way to compare expression in normal and cancerous tissue 
with e.g. expression levels in related or proximal tissues at the same time while also 
presenting that data for study separately.  Furthermore, the expression data are often 
assumed to be correct and no quality control tools are made available at CGAP, dbEST 
and GEPIS.  In this study the CGAP tools were recreated with the aim of enabling a 
wider range of tissues to be searched and compared in a single search.  The CGAP tools 
were found to contain many errors in their library and gene parsing algorithms, for 
which solutions were implemented in the recreated algorithms.  A method was also 
devised for the tissue origin of EST libraries to be verified and for the uncharacterised 
libraries to be annotated with a likely tissue of origin using EST data alone.  An initial 
list of tissue-specific genes was optimised to create gene expression matrices which 
could be used to determine the tissue origin of a library.  The matrices were 
demonstrated to show potential for cancer staging and for the indication of the degree of 
normalisation of a library in addition to tissue typing, making tissue-specific expression 
a suitable quality control method for expression data.  Together the improved 
expression profiling algorithm and the expression matrices provide new tools to assess 
the quality of EST data and their suitability for expression profiling. 
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1. Background 
1.1. Introduction 
The UniGene database (National Center for Biotechnology Information, n.d.a) contains 
6,877,952 ESTs (expressed sequence tags) for humans mapping onto 129,525 UniGene 
Clusters, each of which represents an mRNA transcript (as of 20 July 2012).   Similarly, 
as of 10 February 2012, the Probe database (National Center for Biotechnology 
Information, n.d.b) contains 11,835,370 nucleotide sequences of many different kinds 
which have been collected in a variety of investigations including gene expression 
studies and genome mapping experiments. 
 
These large amounts of data require new approaches to annotation and access the data.  
Both UniGene and Probe host search algorithms that enable the database to be queried 
for data the user wishes to access.  Other relevant databases and search tools include 
ArrayExpress Archive (European Bioinformatics Institute, 2012), Gene Expression 
Omnibus (National Center for Biotechnology Information, n.d.c) and the Cancer 
Genome Anatomy Project (CGAP) (National Cancer Institute, n.d.a). 
 
ESTs have previously been used for novel gene discovery and gene mapping (Adams et 
al, 1991; Gudas et al, 1999; Lee et al, 2001) and the ever increasing amount of data can 
be examined to report gene expression levels and compare them between different 
tissues or conditions.  CGAP exists to provide bioinformatics for the analysis of gene 
expression in cancer and the comparison of this with expression in normal tissue 
(Strausberg, 2001).  These tools allow analysis of a variety of different types of cancer 
such as breast cancer, and are very good and useful in principle. 
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1.2. The Cancer Genome Anatomy Project 
This database, which contains EST and SAGE (Serial Analysis of Gene Expression) 
data, will be used in this project.  Managed by the US National Cancer Institute (NCI) 
and operational since 1996, CGAP’s (National Cancer Institute, n.d.a) aim is to provide 
the information and technological tools needed to decipher the molecular anatomy of 
the cancer cell (Riggins and Strausberg, 2001).  Since then CGAP tools have been used 
worldwide for the analysis or for validation of the differential gene expression in e.g. 
brain cancers and retinoblastomas (Beaty et al, 2007; Loging et al, 2000; Shostak et al, 
2003; Yang et al, 2008), breast cancer (Petersson et al; 2010; Shen et al, 2005; Yousef 
et al, 2004a), colon cancer (Ahmed et al, 2007a, 2007b; De Young et al, 2002; Deyoung 
et al, 2002; Haung et al, 2006; Nam et al, 2005; Yousef et al, 2004b), gastric cancer 
(Meng et al, 2007), lung cancer (Bidon et al, 2001), pancreatic cancer (Alaiya et al, 
2000; Elek et al, 2000; Yousef et al, 2004b, prostate cancer (Mitas et al, 2002; Wu et al, 
2006) and haematological malignancies (Sher et al, 2005) to name just a few.  The 
improved methods of analysing and mining this data include an NCBI classification 
system based on hierarchically related keywords, assigned to each new library by NCI 
staff.  Furthermore, CGAP (National Cancer Institute, n.d.a) hosts two bioinformatics 
tools, the cDNA xProfiler (National Cancer Institute, n.d.b) and the cDNA Digital Gene 
Expression Displayer (DGED) (National Cancer Institute, n.d.c), which are designed to 
enable a user to identify differentially expressed genes, e.g. between a cancer and a 
normal tissue, or compare gene expression between two user-selectable pools of EST 
libraries. 
 
The data used by both tools is derived from the UniGene repository (National Center for 
Biotechnology Information, n.d.a), a publicly available relational EST library database 
maintained by the US National Center for Biotechnology Information (NCBI) in which 
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the tag counts from submitted human or house mouse EST libraries are mapped onto 
UniGene IDs, the unique transcripts they most closely match.  NCBI uses tissue 
type/sample type annotation to create an ontology hierarchy in which libraries are 
grouped into tissue types according to tissue dependency (bone marrow, for example is 
a constituent of bone tissue, so bone marrow libraries are listed under bone tissue).  The 
user-submitted tissue type annotations are listed for each library under the "keywords" 
and "unique tissue" fields, see Figure 1, which shows the first entry of the CGAP EST 
library database. 
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Figure 1. CGAP library database entry.  Each field entry begins with its heading, 
shown in capital letters, followed by the value associated with that field, after the colon. 
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The CGAP tools use the values associated with the "keywords" field, to include or 
exclude libraries from a search based on the chosen tissue type and the inclusion of any 
dependent tissues under the selected one in CGAP’s ontology hierarchy.  Using this 
field, which also includes information on a library’s histology, libraries from a 
secondary tumour (for example, neuroblastoma which has metastasised to bone 
marrow) can also be listed under the tissue in which the primary tumour is located 
(brain in the case of neuroblastoma) (Murray et al, 2007; Ootsaka et al, 2008). 
 
cDNA DGED relies on a publically accessible relational database (National Cancer 
Institute, n.d.d), whilst the cDNA xProfiler accesses a single-file database, not available 
for online access, and uses a Boolean search to identify the presence or absence of a 
transcript in either or both of two groups (pools) of libraries which the user has chosen 
to compare to find differentially expressed genes.  It lists the results as a table detailing 
how many matching transcripts have a known or unknown name and/or function (listed 
as known or unknown) and how many are found only in the libraries in the two pools or 
in at least one library outside the two pools (listed as unique or non-unique (National 
Cancer Institute, n.d.e), also reviewed in (Murray et al, 2007). 
 
Although the presence of a transcript in a particular library can be revealing, the 
outcome would depend on many parameters, including the size of the libraries used, and 
is therefore of limited biological significance.   To overcome this, the cDNA DGED 
calculates sequence odds ratios for individual transcripts expressed in the two pools (Lal 
et al, 1999) and calculates the statistical significance for the difference in the expression 
level of each gene between the two pools.   Thus the cDNA DGED yields the most 
biologically relevant prediction – the normalised odds ratio, which at least in principle 
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should be comparable to the results obtained through other methods based on Northern 
hybridisations or DNA microarrays. 
 
The interface, see Figure 2, is straightforward and the calculations appear to be reliable.  
The relational database used by the cDNA DGED is also available in raw data format, 
enabling the use of alternative tools for interrogation.  The same interface is used by 
both tools because they serve the identical purpose of finding genes which are 
differentially expressed in cancer compared to normal tissue.  Once a search is initiated 
a list of matching libraries is presented, which the user can modify if they wish.  At this 
point cDNA DGED allows the user to supply values for the statistical filters used by 
this tool to omit transcripts whose upregulation or downregulation does not meet the 
required significance.  Once the library selection and statistical parameters are 
satisfactory, the search for upregulated and downregulated transcripts can proceed. 
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Figure 2. CGAP’s cDNA DGED input page.  This screenshot of part of the input page 
shows the options available for comparing two pools of libraries.  Some of the settings, 
such as tissue type and tissue preparation, apply to just one pool, while other choices, 
such as library group and organism, are applied to both pools. 
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1.3. Other tools which use EST data 
CGAP’s EST databases are not the only EST gene expression databases available.  The 
dbEST (National Center for Biotechnology Information, n.d.d), which is the EST 
division of GenBank, is also available for use and includes the CGAP EST data.  To 
query the dbEST data, tools have been developed such as Digital Differential Display 
(DDD) (National Center for Biotechnology Information, n.d.e) and DigiNorthern (no 
longer available).  DDD provides the user with a list of EST libraries (each of these 
contains EST sequencing data from a single experiment on a single tissue sample) from 
a range of tumour and tissue types for inclusion in each of two pools for comparison, 
while DigiNorthern allowed the user to enter one or two query sequences to reveal all 
the cell lines, tissues or organs the genes those sequences map to are expressed in and 
show the relative expression levels between those sources.  If two sequences were 
entered their expression profiles were compared and displayed together.  DigiNorthern 
also provides comparison with any types of cancer the gene is found in (Chen et al, 
2006; Riggins and Strausberg, 2001; Wang and Liang, 2003). 
 
The CGAP tools will be used because they enable two groups of samples, each of which 
may contain many individual sequences, to be compared.  While both tools allow 
species selection at the beginning of a search, the CGAP tools also provide other 
options for displaying libraries matching only the desired tissue type, tissue preparation 
method and so on, and allow the settings for both pools to be selected at once.  dbEST is 
less user-friendly because all the libraries in its database are presented at once for each 
pool without showing the other pool at the same time, and the user has to manually 
select each library they want to analyse for Pool A, and then repeat the process for Pool 
B. 
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Though widely used, the CGAP tools are not the first attempt to effort to acquire gene 
expression data.  Begun in 1991, BodyMap (now unavailable) was the first systematic 
effort to acquire gene expression data and, like CGAP, contains the transcript 
compositions of various human tissues.  Unlike the CGAP tools, in which the user 
chooses two tissues and is presented with differential gene expression levels in those 
tissues, BodyMap requires the user to enter a single sequence or UniGene Cluster ID of 
their choice to discover expression levels for that transcript in different body tissues.  
Thus, unlike CGAP, it was not suitable for high-throughput analyses, and therefore is 
not so suitable for comparing all the transcript levels in one sample with those in 
another (Kawamoto et al, 2000). 
 
The mechanisms underpinning changes in gene expression can often be better 
understood through the analysis of the expression levels of genes neighbouring those 
initially found to be differentially expressed.  GEPIS (Gene Expression Profiling In 
Silico) (Genetech Inc, n.d.) not only compares gene expression in normal and cancerous 
tissues based on EST data, but presents a graphical view of a region of interest in the 
genome to show the expression patterns of neighbouring genes (Zhang et al, 2004).  
However, the results do not take into account alternative splicing, for each gene is 
considered as a single entity without mention of multiple transcripts which might be 
produced. 
1.4. EST and SAGE Libraries 
ESTs are created by sequencing cDNA libraries.  To create a cDNA library, the 
sample’s RNA content is extracted (Peterson et al, 1998), before being purified (Israeli 
et al, 1993) and copied by reverse transcriptase to form cDNA (Coutelle et al, 1985).  
Once the cDNA library has been created, ESTs are produced by sequencing randomly 
selected transcripts, usually from the 3’ end to generate single read fragments which are 
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often longer than several hundred base pairs in length.  These are then assembled into 
longer, overlapping sequences mapped onto the original transcript.  Though originally 
used for gene discovery, ESTs can also be used for expression profiling.  mRNA 
expression levels are inferred by counting the absolute number of tags representing each 
transcript, and it is for this reason that this technique is sometimes referred to as a 
“digital” gene expression profiling method.  EST libraries contain a snapshot of mRNAs 
expressed in the sample from which the library was created (Shmulevich and Zhang, 
2002).  EST expression profiling is a well-established high-throughput method for 
acquiring quantitative information on a sample’s transcriptome and for studying 
differential gene expression, inferred from the differences in the relative numbers of 
EST tags between two libraries. 
 
ESTs are sequence reads which enable the absolute expression levels of all the genes in 
a sample to be determined, as is also the case with a related technique called Serial 
Analysis of Gene Expression (SAGE).  However, instead of concatenating the tags 
together as is done for SAGE, ESTs are individually sequenced, and differential 
expression is inferred from comparing the number of tags representing each gene in 
each of two samples to the total size of each sample.  This makes EST advantageous 
over SAGE in the event of a sequencing error, which will only affect the EST 
concerned, whereas a whole SAGE concatamer (Ichikawa et al, 2004), containing many 
individual tags, will be impacted.  Furthermore, with lengths of more than a few 
hundred base pairs, ESTs are significantly longer than SAGE tags, which are far more 
likely than ESTs to map onto two or more transcript simultaneously due to their short 
length.  Thus the use of ESTs vastly reduces the risk of ambiguity in the results (Adams 
et al, 1991; Audic and Claverie, 1997; Pariset et al, 2009; Simon et al, 2009). 
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If the purpose of an EST library is for gene discovery rather than expression profiling, 
the EST content of a library can be altered to reduce the abundance of transcripts 
representing genes with high expression.  To achieve this, a library can be normalised 
by removing the most abundant transcripts in order to reduce or eliminate the 
differences in the relative transcript abundances to a narrow range (Arhondakis et al, 
2006; Bonaldo et al, 1996; Sasaki et al, 1994; Soares et al, 1994). 
 
To increase the likelihood of discovering novel genes, cDNA libraries can be 
normalised, a process in which the most abundant sequences are removed to bring the 
transcript abundances to within an order of magnitude of one another.  Ideally this 
should create a library containing the same tag counts for the low abundance sequences 
as before, but with vastly reduced counts for abundant cDNAs.  cDNA libraries can also 
be subtracted, a process in which, in addition to normalisation of the library, all 
previously known sequences are removed, producing a subtracted library which ideally 
contains only novel transcripts whose abundances are within an order of magnitude of 
one another (Bonaldo et al, 1996). 
 
At the beginning of the normalisation process single-stranded cDNA is produced from 
the double-stranded plasmids.  This can be done either in vitro (Bonaldo et al, 1996) or 
by transformation into bacteria (Panja et al, 2006) and infection with the helper phage 
MK13K07 (Soares et al, 1994).  Because the rate of an enzymic reaction is directly 
proportional to the substrate concentration, using both techniques, proportionately less 
of the low abundance species will be present in single-stranded form at the end of the 
procedure, compared to the cDNA species which are more abundant and therefore 
present in higher concentration.  Thus, a transcript for which there are 10,000 copies 
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present will be digested at a rate ten times greater than the rate of digestion of a 
transcript for which there are only 1,000 copies present. 
 
To remove any contaminant single-stranded DNA and therefore produce a mixture 
containing only the rarer transcripts, the whole mixture is passed down a column 
containing hydroxyapatite, to which the double-stranded molecules preferentially bind 
due to their greater negative charge (Andrews-Pfannkoch et al, 2010). 
 
The above procedures may be repeated at least once on the bound fraction to increase 
the enrichment of the library for low abundance transcripts and therefore increase the 
degree of normalisation.  In order to do this a second strand is synthesised on each 
plasmids (Bonaldo et al, 1996).  At the end of the procedure an ideal normalised library 
will have the same number of plasmids containing each cDNA species. 
 
The above procedures should result in reduced (ideally identical) transcript abundances 
and therefore a lower mean EST count per transcript than the equivalent non-normalised 
library.  As a consequence of this, in a normalised library there should also be more 
transcripts detected after the same amount of sequencing. 
1.5. Cancer 
1.5.1. The cell cycle under normal conditions 
The CGAP tools exist to allow the molecular changes which occur during oncogenesis 
to be better understood.  These changes cause the cell concerned to divide indefinitely 
rather than in response to external signals.  This makes the cell cancerous, and the cell 
will continue to divide to form a clump of cells called a tumour.  The molecular changes 
which cause this indefinite proliferation involve deregulation of the cell cycle (the cycle 
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of duplication and division of a cell), which is divided into the G1, S, G2 and M phases 
(Morgan, 2002; Weinberg, 2007). 
 
In the S (synthesis) phase DNA replication occurs, taking 10-12 hours in mammalian 
cells, which will be the focus of this report.  The resulting two identical sets of 
chromosomes are segregated and the cell divides in M (mitosis) phase.  During this 
phase the cell takes under an hour to complete a series of events which begin with 
mitosis (nuclear division, in which the two sets of chromosomes are separated to 
opposite ends of the cell) and end with cytokinesis (division of the cytoplasm into two 
daughter cells). 
 
The G1 and G2 phases are gap phases that allow the cell to grow by doubling its mass of 
proteins and organelles, a process which takes far longer than the 11-13 hours required 
for the S and M phases (Morgan, 2002). 
 
Each stage is under the control of various protein complexes and signalling pathways, 
some of which induce progress through the cycle, and therefore promote cell 
proliferation, and some of which repress proliferation.  The signalling pathways act as 
quality control mechanisms because they ensure that the cell only divides when it is 
required to do so, and external signals triggering the pathways bring about division. 
 
The protein complexes are called checkpoint complexes and arrest the cell cycle until 
any detected errors in the cell’s mechanisms for DNA replication and chromosome 
duplication and segregation are repaired.  If these errors cannot be repaired the cell may 
enter a resting state called G0 or it could undergo senescence (ageing) or apoptosis 
(programmed cell death) (Figure 3A) (Delaval and Birnbaum, 2007; Morgan, 2002). 
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Figure 3. Changes to the cell cycle which result from the disruption to checkpoint 
complexes in cancer.  A: Cell cycle arrest due to errors detected by undamaged 
checkpoint complexes in normal cell.  B: Continuous cell cycle resulting from 
disruption to the checkpoint complexes due to mutations and gene expression changes 
in cancer. 
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Some of the molecular changes which disrupt the above quality control mechanisms and 
bring about the onset of cancer (Figure 3B) include mutations (changes in gene 
structure), whole others involve changes in gene expression even though those genes are 
not mutated.  Such genes are said to be differentially expressed in cancer compared to 
normal tissue) and can be used as biomarkers in diagnosis or targets for anticancer 
therapy (Larsson et al, 2010; Morgan, 2009; Salama and Platel, 2009; Troncone et al, 
2010; van Eijk et al, 2010). 
1.5.2. The importance of gene expression in diagnosis and treatment 
Cancer biomarkers have been shown to be increasingly important in cancer diagnosis, a 
key part of which is determining what stage of cancer a patient has because tumours are 
stratified into two types according to disease stage.  A benign tumour cannot invade 
adjacent tissues or metastasise to other organs, and will therefore only cause death if it 
presses against nearby organs or causes physiological changes through hormone 
imbalances.  Therefore a patient with a benign tumour has a much greater chance of 
survival than a patient with a malignant tumour, which does invade adjacent tumours 
and metastasise to other organs, causing the majority of cancer-related deaths in the 
process (Weinberg, 2007). 
 
Cancers have traditionally been diagnosed according to their tissue of origin, and the 
stage of the disease, and the method used has usually been their appearance under the 
microscope or location in an MRI scan, a method called histopathology.  Cancer disease 
biomarkers have been used on some occasions to refine traditional methods of 
classification but histopathology has been the usual method (Livingston and Shivdasani, 
2001; Weinberg, 2007). 
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In the last few years, however, investigations have shown that biomarkers could be a 
potential diagnostic tool.  Investigations over that time have begun to alter the way 
different cancers are stratified into groups using the above histopathological methods.  
Cancer disease biomarkers can provide clinicians with an accurate diagnosis, prognosis, 
assessment of treatment options, or likelihood of recurrence.  This is because patients 
with similar histopathological diagnoses can have very different outcomes, and 
histopathological classification gives very little information about the above parameters 
(Arsanious et al, 2009). 
 
For example, an investigation into diffuse large B-cell lymphoma found that this 
disease, previously thought to be one condition, was in fact two molecularly distinct 
diseases whose expression patterns showed similarities to two different B-cell 
differentiation stages.  One type was germinal centre B-cell like DLBCL, which was 
found in 40% of patients who had a significantly better survival rate than the other 60% 
of patients who had the other form, which was activated B-like DLBCL.  Another 
investigation revealed a third type called primary mediastinal lymphoma, which, like 
activated B-cell like DLBCL, has a worse prognosis than germinal centre B-cell like 
DLBCL.  This showed that classifying tumours according to their gene expression 
profiles could identify previously undetected types of cancer, enabling an accurate 
prognosis to be provided and the correct treatment to be administered.  This is 
particularly important because incidence of the three conditions has subsequently been 
found to vary between countries (Alizadeh et al, 2000; Ke et al, 2010; Weinberg, 2007). 
 
Even if tumours are stratified correctly according to more established methods, they 
may still be classified differently according to gene expression profile.  For example, 
gene expression profiling of prostate tumours revealed three distinct subtypes, each of 
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which combined primary tumours and metastases in varying proportions (Lapointe et al, 
2004), suggesting that gene expression profiling may aid in locating the primary tumour 
by studying the expression profile of one or more metastases. 
 
This shows that knowledge of a cancer’s gene expression profile and of changes in 
expression as a consequence of disease progression are essential for diagnosis.  
Furthermore, cancers in different patients need to be correctly stratified because the 
term “cancer” covers a wide range of diseases, each of which has its own characteristic 
gene expression profile and each of which will arise from a different tissue in the body.  
For this reason it is vital that the gene expression profile of each normal tissue is known 
so that cancer samples can be compared with it, both for finding new biomarkers and 
testing patients’ samples for diagnosis, prognosis or monitoring.  Once the gene 
expression levels have been obtained, if they are deposited in the appropriate database, 
bioinformatics tools such as those hosted by CGAP can then be used to analyse the 
results and compare them against any other sample the user chooses to correctly 
diagnose the cancer. 
 
Differentially gene expression has also been shown to be useful in providing an accurate 
prognosis.  This was shown when the expression levels of 70 genes in primary breast 
tumours were found to be an indicator of the likelihood of distant metastasis within 5 
years in 83% of patients studied.  Furthermore, these genes were found to be involved in 
processes essential for tumour development such as cell cycle regulation and 
angiogenesis (blood vessel formation).  Moreover, 70-80% of the patients deemed 
eligible for chemotherapy based on histology and clinical characteristics, would not 
benefit from treatment because the tumour would not have formed distant metastases if 
left untreated.  This shows that gene expression profiling, together with in silico 
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analysis of the results with tools such as those hosted by CGAP, is an essential tool for 
the provision of an accurate prognosis (van’t Veer et al, 2002). 
 
Differential gene expression has also found to indicate the likelihood of cancer 
recurrence.  In a study of grade two breast tumours, a stage at which it is impossible to 
determine the likelihood of recurrence from the tissue histology, analysis of expression 
levels of 97 genes found to be associated with disease stage divided the patients into 
two groups of either high or low risk of recurrence (Sotiriou et al, 2006).  As with the 
earlier mentioned study of diffuse large B-cell lymphoma, this shows that gene 
expression profiling and use of appropriate bioinformatics tools is essential for 
accurately classifying tumours and producing an accurate prognosis. 
 
Differentially expressed genes can be used as targets for anticancer therapy if the 
change in expression is required for the development of the disease.  An example of 
such a gene is the one which encodes VEGF (vascular endothelial growth factor), whose 
expression induces angiogenesis in a wide variety of conditions in which this occurs 
(Neufeld et al, 1999).  It has been shown that targeting VEGF using small interfering 
RNA (siRNA) resulted in almost total inhibition of secretion of this protein in a prostate 
cancer cell line (Takei et al, 2004).  However, the major challenge is identifying 
delivery strategies suitable for clinical use (Bumcrot et al, 2006).  A clinical trial has 
been undertaken using a targeted nanoparticle to deliver siRNA against the M2 subunit 
of ribonucleotide reductase to melanoma tumours.  The result was a reduction in 
expression which correlated with the siRNA dose (Davis et al, 2010). This shows that 
gene expression profiling together with in silico analysis of the results can be used to 
provide novel treatments for cancer. 
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1.6. Current Problems 
1.6.1. Existing CGAP tools do not currently allow all searches which 
might be required for effective gene expression profiling in cancer 
Currently, existing tools (CGAP (National Cancer Institute, n.d.a), DDD (National 
Center for Biotechnology Information, n.d.e) and GEPIS (Genetech Inc, n.d.)) are only 
able to compare two groups of tissues at once, for example cancer from a chosen tissue 
with normal samples from the same tissue.  Thus it is not possible to compare gene 
expression levels in three or more groups of tissues side-by-side in a single search.  For 
example if the aim of the investigation was to study just one type of cancer in a specific 
tissue and ignore all other cancers in that tissue and all related or proximal tissues.  To 
do this using CGAP’s algorithms, multiple searches would have to be carried out, each 
set to present two of the desired groups of tissues, and the results would have to be 
merged using other software.  Such a comparison would enable gene expression within 
the organ concerned to be compared with expression in the rest of the system and with 
that in nearby unrelated tissues, with it still being possible to analyse each set of results 
individually.  For example, genes could be reported which are expressed only in thyroid 
and not in the related parathyroid, the proximal oesophagus or muscle or the connected 
peripheral nervous system and vascular tissue.  The identification of such transcripts 
would improve the reliability and accuracy of any diagnostic or prognostic tests 
developed from suggested biomarkers and would also eliminate possible side effects 
from any new RNAi-based treatment developed against suggested targets. 
1.6.2. Data is currently assumed to be correct with no means of 
quality control 
Furthermore, the underlying data still requires a quality control method which would 
enable the identity of each library to be verified independently of any external 
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information.  This is required because the methods used to generate EST libraries such 
as RT PCR and random selection of cDNAs for sequencing can introduce biases into 
EST data (Liu and Graber, 2004).  During any one cycle of a PCR reaction one DNA 
molecule can be amplified more than once (Song, 2003).  This disproportionate 
amplification will lead to abnormally high expression levels of those sequences 
appearing in the final results (Ray et al, 2004).  Errors can also be introduced because a 
significant percentage of mRNA species contain multiple polyadenylation sites, 
potentially leading to multiple ESTs being produced from one transcript (Beaudoing et 
al, 2000).  Such errors may lead to false positive results or the omission of potential 
diagnostic biomarkers or therapeutic targets from further investigations, which in turn 
may lead to erroneous diagnoses or incorrect treatments. 
 
Analysis of gene expression data for quality control purpose has been attempted 
previously with SAGE data (Huminiecki et al, 2003).  Three databases were compared – 
Gene Expression Atlas (oligonucleotide microarray data), SAGEmap (SAGE libraries) 
and TissueInfo (EST libraries).  Because these databases use different formats for 
sample annotation and use different statistical methods for data analysis, a method 
called Preferential Expression Measure (PEM) was devised to score differential 
expression of genes in libraries grouped into six different tissue categories (brain, 
kidney, ovary, pancreas, prostate and vascular endothelium) in three databases.  Inter-
database correlations were measured and were found to be high for brain, prostate and 
vascular endothelium, but not for kidney, ovary and pancreas.  However, inter-library 
correlations have yet to be applied as a quality control method within one database 
(Huminiecki et al, 2003). 
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In a more recent study, data for 8,570 genes across 46 human tissues from the Gene 
Expression Omnibus (an Affymetrix microarray data repository) were categorised 
according to tissue specificity and subcellular localisation of their protein product (Li et 
al, 2011).  The authors reported that widely expressed genes have higher expression 
levels than genes which are expressed in one or a few tissues (Li et al, 2011). 
 
While many quality control methods were previously suggested, they only focussed on 
the whole genome (Liang et al, 2006) or covered aspects of the data such as GC content 
(Arhondakis et al, 2006), with few investigations focusing on the tissue-specificity 
issues (Russ and Futschik, 2010).  A common shortcoming of many previous reports is 
that tissue specificity of the genes was reported (Hu et al, 2000; Krief et al, 1999; Miner 
and Rajkovic, 2003; Pao et al, 2006; Vaes et al, 2002) but no attempts were made to 
actually use such data for quality control or evaluation of the expression data.  
Moreover, even unique "tissue specific genes" might be of little use if they are 
expressed at low levels and would therefore be absent in many smaller libraries.  This is 
because the quality of a library could depend on the depth of sequencing (the number of 
ESTs sequenced for inclusion in the library).  A greater depth of sequencing would 
provide a better quantitative estimate of gene expression (Simon et al, 2009) because 
low-abundance transcripts are more likely to be included (Bashir et al, 2010), making 
the library more representative of gene expression in the original sample.  It is for this 
reason that the effect of library size on gene expression results has been previously 
studied and/or taken into account in statistical tests, which have been applied to a range 
of different types of cancer (Abba et al, 2004; Baggerly et al, 2003, 2004; Robinson and 
Smyth, 2007; Ruijter et al, 2002; Silveira et al, 2008; Thygesen, 2006).  However, the 
effect of library size on inter-library correlations has not been previously studied, 
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despite it being known that this parameter impacts the reliability of the results (Schaaf 
et al, 2008). 
 
Furthermore, many existing tools and secondary databases, including the CGAP, are 
simply sophisticated information retrieval tools, lacking numerical methods for 
verification of the EST counts and sample origins.  The EST counts are assumed to be 
correct and the libraries to be correctly annotated (Elfilali et al, 2006; Strausberg et al, 
2002; Zhang et al, 2004).  The existing algorithms used to analyse EST expression data 
place the emphasis on identification of the degree of over/under-expressed for 
tissue/disease-specific genes by comparing EST counts between two library pools 
without fully evaluating the quality of the expression data or the origins of the 
experimental material used, these are simply assumed to be correct and no numerical 
methods for their verification are made available (Elfilali et al, 2006; Strausberg et al, 
2002; Zhang et al, 2004).  It is not surprising that many such tissue distribution 
resources are quickly superseded by more recent developments or are being taken 
offline (Brown et al, 2004; Kawamoto et al, 1996; Okubo et al, 1992; Skrabanek and 
Campagne, 2001).
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2. Aims and Objectives 
2.1. Aims 
The main aim of this research was to create a new quality control method for gene 
expression data and improved bioinformatics methods used to analyse differential gene 
expression, particularly in cancer.   
 
We aimed to address the so far unresolved problem of controlling the quality of EST 
expression data.  The usefulness of any such expression data depends overwhelmingly 
on the provided annotations and there is virtually no way of experimentally testing any 
of the datasets.  Since annotations are often incomplete and inconsistent we decided to 
investigate if the quality of expression data could be tested on the data alone, rather than 
the annotations.  Such a capability would enable the characterisation of libraries from 
unknown or un-annotated tissue samples, as well as the identification of libraries whose 
annotation is erroneous or whose identity is obscured by experimental error. 
 
We also aimed to investigate whether partially normalised libraries, which are normally 
considered to be unsuitable for quantitative analysis of differential gene expression 
because of the changes in relative transcript abundance, could be identified from the 
expression data (not the annotations) and still used for quantitative expression profiling.  
 
We also sought to investigate whether cancer staging could be undertaken by correlating 
their expression data with that of normal libraries of known tissue identity, instead of 
merely relying on the cancer libraries’ annotation, which may not always be correct.  
We also studied whether the degree of normalisation of a normalised library could be 
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obtained in a similar manner.  Similarly, we intended to look into breast cancer 
stratification and whether this can be aided using the developed methods.  
 
Finally, using simple model data, we aimed to test our data evaluation method on small 
libraries to assess whether it could be used to correctly obtain the tissue identity of such 
libraries, which are equivalent in size to some of the smallest and least representative 
libraries in CGAP’s database. 
2.2. Objectives 
1. The first objective was to learn the CGAP algorithms by recreating them using 
Microsoft Excel. Having done that we also created an easy to use development tool so 
we could improve and modify any of the analysis methods.  
2. As part of the creation of the new algorithm the second objective was to correct errors 
in the existing algorithms, which we suspected have existed at the time of embarking on 
this project and which became apparent whilst addressing first objective. 
3. The third objective was to include the facility for selecting more than two pools of 
tissues for side-by-side comparison in a single search (as opposed to the two allowed at 
present by CGAP’s algorithms and other basic comparison tools.  This would enable, 
for example, genes to be investigated which are expressed only in one specific cancer of 
interest from a particular tissue, and not in any other type of cancer from that tissue or 
the normal tissue, as well as related or proximal tissues, with each tissue presented 
separately so its gene expression profile can be individually studied. 
4. The fourth objective was to create a gene expression matrix with a small number of 
genes with known expression levels across the tissues, and to use these patterns of 
expression levels to elucidate (i) the tissue identity of libraries, (ii) normalisation status, 
(iii) to discriminate normal versus cancer-derived libraries, (iv) to attempt cancer 
staging. 
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5.  The fifth objective was to study the potential of the EST expression matrix in 
identifying normalised libraries and indicating the degree of normalisation, using 
annotated normalised libraries as well as simple modelled data.  Having done this we 
investigated the potential of the matrix in cancer staging, using annotated cancer 
libraries.
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3. Materials and Methods 
3.1. Materials 
All experiments were carried out using 64-bit Microsoft Excel 2010 on a 64-bit 
Windows 7 workstation with 16GB of RAM.  The CGAP EST expression data 
(National Cancer Institute, n.d.d) were used for the development of a Microsoft Excel-
based tool.  Data downloaded on 15 November 2008 was used to compare the number 
of transcript-mapping ESTs reported for a group of libraries with the library size 
annotations of those libraries.  Data available on 2 July 2009 was used to produce the 
preliminary list of 1,437 transcripts in the creation of a quality control method based on 
tissue-specific expression.  Data downloaded on 18 August 2010 was used to optimise 
that list to 244 transcripts and investigate the potential use of that list as a quality 
control method.  Data downloaded on 9 March 2011 was used to study CGAP’s 
statistics and investigate empty and missing database entries. 
3.2. Methods used to analyse the existing CGAP tools for errors 
3.2.1. Analysis of the library parsing algorithm 
For each of the 56 "specified" tissues in CGAP’s database a search was carried out 
using CGAP’s cDNA xProfiler in which all libraries associated with that tissue were 
reported.  All library protocols, tissue preparation methods and tissue histology 
annotations were included, and the “sequences” cut-off was set to zero, with the tissue 
type set to the tissue of interest.  The settings were the same for both pools.  This was 
done to present as many libraries as possible, regardless of whether they contained a 
representative profile of in vivo gene expression.  The data used was that accessed by 
the cDNA xProfiler on 14 May 2010. 
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Each library reported for each tissue was studied to assign that library as correctly or 
incorrectly reported for that tissue.  A library was considered correctly reported if its 
“unique tissue” annotation precisely matched the selected tissue type.  All other libraries 
were considered incorrectly reported.  The phrases “germ cell,” “head and neck” and 
“stem cell” were not contained in any libraries’ unique tissue annotations, so libraries 
were considered to be correctly reported for these tissues if their “keywords” 
annotations contained one of these phrases. 
 
The bone search to test whether libraries from dependent tissues are consistently 
included with their parent tissue was performed on 25 January 2012.  All of these 
experiments were performed by Andrew Milnthorpe. 
3.2.2. Analysis of the cDNA xProfiler transcript lists 
To check the lists of transcripts produced by the CGAP tools normal adipose tissue 
(Pool A) and cancerous adipose tissue (Pool B) were compared using both the cDNA 
xProfiler (National Cancer Institute, n.d.b) and cDNA DGED (National Cancer 
Institute, n.d.c), using the version of these tools available from on 16 March 2010.  Bulk 
and non-normalised libraries were used.  The “number of sequences” display cut-off 
was set to zero to include all libraries.  When running searches using cDNA DGED the 
Bayesian probability "P" value and the calculated odds "F" ratio display cut-offs were 
both set to one to ensure that all transcripts were displayed to enable comparison of the 
results with those produced by the cDNA xProfiler, which does not have statistical 
filters. 
 
The problem of the cDNA xProfiler’s results table misreporting some non-unique 
transcripts as unique was discovered when bulk non-normalised non-cancerous tissue 
(Pool A) was compared with bulk non-normalised cancerous tissue (Pool B).  The 
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“sequences” display cut-off value was set to zero to include all libraries, and a search 
was undertaken for each of the 52 available tissues, with the tissue of interest chosen for 
each search.  This was carried out using the version of the cDNA xProfiler available 
between 14 November 2011 and 17 November 2011.  For tissues with which the 
problem occurred, further searches using the same settings were carried out for those 
tissues only.  Unlike previous searches, during the library selection stage, the search 
was repeated multiple times, each with a different selection of libraries, until the cause 
of the problem was found.  All of these experiments were carried out by Andrew 
Milnthorpe. 
3.2.3. Estimating the reliability of the cDNA DGED’s statistical 
prediction of the reliability of gene expression 
To test two different “F” value display cut-off settings, two CGAP cDNA DGED 
searches were run to compare normal bone with cancerous bone (accessed on 22 August 
2011).  Bulk non-normalised bone libraries were used, with normal tissue selected for 
Pool A and cancerous tissue selected in Pool B.  The “number of sequences” display 
cut-off was set to zero to include all libraries.  The bone libraries chosen were the ones 
whose unique tissue field contained the exact phrase “bone” and all other libraries that 
the CGAP tools map onto bone tissue were excluded.  The “Q” value display cut-off 
was set to one for both searches to present all results regardless of their reliability. 
 
The “F” value display cut-off was set to two for the first search to display every gene 
whose expression differed between the two pools by a factor of two or more.  The “F” 
display cut-off was set to three for the second search to display every gene whose 
expression differed between the two pools by a factor of three or more.  The output of 
the online search results was analysed for three genes whose “Q” values were close to 
zero when the “F” value cut-off was set to two and these “Q” values were compared 
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with those obtained when the “F” value display cut-off was set to three.  All of these 
procedures were undertaken by Andrew Milnthorpe. 
3.2.4. Experiments to study CGAP’s database files 
The comparison of normal adipose tissue with cancerous adipose tissue described above 
was repeated using CGAP's cDNA DGED (the database was last accessed on 6 January 
2010).  The number of ESTs contained within the libraries of each pool was counted for 
each pool (by summing together the values reported for the individual libraries from 
CGAP's library database annotations).  This value was compared with the value 
reported by CGAP DGED gene list for the number of ESTs mapping onto all transcripts 
in the chosen libraries. 
 
The CGAP raw data was examined to discover the erroneous annotation of library 
“SARS-Cov infected lung tissue” as containing no ESTs.  To investigate further, a 
search was run using CGAP’s cDNA DGED in which all libraries were present in all 
pools.  All tissues, tissue preparations, library protocols and tissue histologies were 
included in both pools, and the “number of sequences” display cut-off was set to zero.  
This was undertaken on 26 January 2012. 
 
The version of the CGAP database available for download on 9 March 2011 was 
searched using Excel to count the number of expression database records listed for 
libraries not presented in the library database.  In the same way the number of library 
database records included for libraries containing no transcript-mapping ESTs was also 
counted.  The number of “gene database” records listed for transcripts which did not 
map onto any ESTs in any libraries was similarly recorded.  All experiments were 
undertaken by Andrew Milnthorpe. 
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3.3. Methods used to solve problems identified during 
investigation of CGAP’s databases and algorithms 
3.3.1. Configuration of new library search algorithm to solve 
problem of incorrect or irrelevant libraries being reported by CGAP 
Microsoft Excel was used to test the new library parsing algorithm.  Initially this was 
designed to mimic CGAP tools and present the same libraries for each tissue as do the 
CGAP tools, so the transcript parsing algorithm and the reported number of ESTs per 
library could both be compared with CGAP’s equivalents.  Without this it would not be 
possible to report any differences in the reported EST counts and the “gene results” 
compared to the CGAP tools as being solely due to differences in those two features 
between the tools. 
 
The new algorithm was then modified to assign libraries to tissues using their "unique 
tissue" field to present only the libraries which are associated with the selected tissue. 
Once this was done, a search for each available tissue was undertaken in which all 
libraries for that tissue were reported, regardless of whether they contained a 
representative profile of in vivo gene expression.  Therefore all tissue preparation, 
library protocol and tissue histology choices were included and the “number of 
transcript-mapping ESTs” threshold was set to zero.  This was carried out using the 
version of CGAP’s data available on 2 January 2010.  All studies were undertaken by 
Andrew Milnthorpe. 
3.3.2. Creation of novel transcript search algorithms to resolve issue 
of different transcript lists being reported by CGAP 
Also using Microsoft Excel, two new transcript search routines were designed (unlike 
the CGAP tools, these were called transcript searches rather than gene searches).  One 
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reports the presence or absence of that transcript in each pool of libraries, as reported by 
the cDNA xProfiler.  The other reports the number of ESTs mapping onto that transcript 
in all of the libraries included in each pool and calculates the odds ratio for each 
transcript between the two pools, as does CGAP’s cDNA DGED.  Both algorithms rely 
on the UniGene Library ID (the unique identifier) of each of the chosen libraries in the 
expression datasheet of the UniGene relational database used by cDNA DGED.  This 
table lists the transcripts in each library along with the number of ESTs in that library 
which represent each of those transcripts.  The UniGene Cluster ID (the unique 
identifier) of each transcript, which is used to identify it in the expression datasheet, is 
used to search the transcript datasheet for the details of that transcript.  These are 
reported in a transcript list.  The presence or absence of each of the presented transcripts 
in each pool of libraries and the number of ESTs mapping onto that transcript in all 
pooled libraries are reported. 
 
The new transcript parsing routines were tested by comparing a set of normal bone 
libraries with a set of libraries from cancerous bone.  The chosen libraries were made 
from bulk bone tissue and had not been normalised during their preparation, thus 
matching as closely as possible the in vivo gene expression levels.  The libraries used 
were the same as those presented by the online CGAP tools for bone tissue, in order to 
show that any differences in the gene results were due to differences in the transcript 
parsing algorithms and not due to differences in the library parsing algorithms.  The 
“sequences” cut-off was set to zero to include all qualifying libraries of any size.  All 
experiments were carried out by Andrew Milnthorpe. 
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3.3.3. Methods used to correct problem of CGAP statistics reporting 
different output values for different input display filter settings 
Statistical methods implemented in CGAP DGED involve the calculation of a 
Benjamini Hochberg False Discovery Rate “Q” value for each gene (Benjamini and 
Hochberg, 1995) from a probability “P” value calculated using the Fisher Exact Test 
(Daya, 2002).  Unlike CGAP, the Fisher Exact Test reported by Daya (Daya, 2002) was 
implemented alone using the following equation (Daya, 2002): 
 
𝑃 =  
(𝑎+𝑏)!(𝑎+𝑐)!(𝑏+𝑑)!(𝑐+𝑑)!
𝑁!𝑎!𝑏!𝑐!𝑑!
    (1) 
 
Where P is the probability that the observed expression is not due to sampling error, a is 
the number of ESTs mapping onto the transcript in Pool A, b is the total number of 
ESTs in Pool A minus the number of ESTs for the transcript in Pool A, c is the number 
of ESTs mapping onto the transcript in Pool B, d is the total number of ESTs in Pool B 
minus the number of ESTs for the transcript in Pool B, and N is the total number of 
ESTs in both pools. 
 
That equation was used to calculate the probability (reported in the manner of a Chi-
squared “P” value (Yousef et al, 2004a)) of the observed expression difference for each 
transcript being due to chance in a comparison of a group of bulk non-normalised 
normal bone libraries with a group of bulk non-normalised cancerous bone libraries (the 
relevant CGAP database was available for download on 9 March 2011).  The “number 
of ESTs mapping onto transcripts in library” display cut-off was set to zero to ensure 
that the libraries studied were the same as those included in the equivalent CGAP search 
mentioned above.  The bone libraries whose “unique tissue” field contained “bone” 
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were the only ones reported, and the additional libraries the CGAP tools map onto bone 
tissue were not presented. 
 
The factorials shown in Equation (1) were calculated using Stirling’s Approximation, a 
method for efficient and highly accurate approximation of large factorials (Bracken, 
2003; Mortici, 2011).  The “P” values calculated using Equation (1) range between zero 
and one.  The statistically significant values are those closest to zero, in the manner of a 
Chi-squared “P” value (Yousef et al, 2004a).  To check whether the “P” values 
calculated using Equation (1) change when the display cut-off value “F” is changed, the 
transcript parsing algorithm was run twice, once with the “F” display cut-off set to two 
and once with the “F” display cut-off set to three. 
 
The difference between these statistics and those used by CGAP is that the CGAP 
cDNA DGED calculates a “Q” Benjamini-Hochberg False Discovery Rate value from 
the Fisher Exact “P” values as shown below (Benjamini and Hochberg, 1995). 
 
𝑄1 = 
𝑃1
𝑛
, 𝑄2 = 
𝑃2
𝑛−1
, 𝑄3 = 
𝑃3
𝑛− 2
…𝑄𝑛 = 
𝑃𝑛
1
   (2) 
 
Where Q is the Benjamin-Hochberg False Discovery Rate for each gene, P is the Fisher 
Exact Probability value for each transcript, and n is the number of transcript expressed 
in either or both pools. 
 
All experiments were undertaken by Andrew Milnthorpe. 
45 
3.3.4. Rectification of incorrectly reported library sizes and empty or 
missing database entries 
For each library the number of ESTs representing all the genes in that library were 
routinely counted and reported by the transcript-parsing algorithm created using Excel 
to resemble that of CGAP’s cDNA DGED.  These values were compared to the ones 
reported by both CGAP tools’ library lists and the number of ESTs mapping onto the 
transcripts in the same libraries as reported by cDNA DGED’s transcript list for a 
comparison of bulk non-normalised libraries from non-cancerous bone (Pool A) with 
bulk non-normalised cancerous libraries from bone (Pool B).  The respective library 
size display cut-off settings were set to zero so that all qualifying libraries were present 
for comparison.  The data available for all searches was that available from CGAP on 
15 November 2008. 
 
The presentation and use of the number of ESTs mapping onto transcripts in each 
library instead of CGAP’s “sequences” annotations was also used to solve the problem 
of the erroneous annotation of the library entitled “SARS-Cov infected lung tissue” as 
containing no ESTs. 
 
The problem of the inclusion of empty libraries, unmapped transcripts and unlisted 
libraries in CGAP’s database was corrected using Excel so that the empty libraries 
would not be reported in the library list of the Excel-based tool and so that Excel-based 
searches would take less time due to the unlisted libraries and unmapped genes not 
being present.  To achieve this all such entries were deleted from the database files used 
by Excel.  All procedures were undertaken by Andrew Milnthorpe. 
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3.4. Procedures undertaken to further improve the new tools 
The new tools were programmed using Excel 2010’s Visual Basic for Applications.  
The implementation of multiple pools in the library parsing algorithm and the inclusion 
of the formula in the algorithm based on CGA’s cDNA xProfiler for filtering the 
transcript list were originally carried out previously for an MSc in Biological Sciences 
Research, also at Royal Holloway, which was completed in August 2008.  Everything 
else presented in section 4.3, and all other work presented in this thesis, was undertaken 
since October 2008 for this PhD. 
3.5. Methods used to create a procedure for the quality control 
of EST data 
3.5.1. Selection of tissue specific transcripts 
Candidate tissue-specific transcripts were selected based on a number of criteria.  
Firstly, CGAP database was manually searched for the highly abundant and tissue-
specific transcripts (each of these unique cDNA species has an entry in CGAP’s 
database, where it is annotated with a UniGene cluster ID as its unique identifier) 
defined by their EST counts, for all individual tissue types available using the cDNA 
DGED (National Cancer Institute, n.d.c) on 15 October 2009.  Separate searches were 
conducted for "Normal" and "Cancer" histology for all tissue types.  The minimum 
number of sequences per library was set at 10, the tissue preparation was set to "bulk" 
and the library protocol to "non-normalised" in all searches.  The EST library group was 
set to "All", which included all CGAP, MGC, ORESTES and un-annotated libraries, the 
latter constituted the vast majority (~72%) of all the libraries used.  The transcript lists 
were downloaded from CGAP and then searched for the transcripts with the high odds 
ratio (i.e. the normalised EST abundance in the selected tissue type divided by 
normalised abundance in all other libraries, typically above 10), which was also 
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statistically significant (typically P < 0.05).  Additional selection criteria were high 
relative EST expression levels in the targeted tissue (typically above 0.1% of all the 
ESTs counts) and low expression levels in the rest of tissue types (typically below 0.1% 
of all the ESTs counts).  Where possible only ESTs identified in at least two libraries 
and counted at least three times in the tissue studied were selected.  Up to thirty 
individual transcripts having the highest odds ratios and meeting all of the above criteria 
were selected from each of the individual tissue types.  Where less than thirty or none 
were available, the selection criteria were relaxed and the transcripts which satisfied 
most of the search criteria were selected.  These steps were carried out by Andrew 
Milnthorpe.  All the transcripts were combined (totalling 2,295 from all tissues types) 
and the duplicates were removed, yielding 1,089 individual UniGene cluster IDs.  This 
final step was performed by Mikhail Soloviev. 
 
The second round of search for additional tissue markers was on the basis of their 
absolute abundance level only.  For this EST counts for each of the 37,575 different 
transcripts from 155 non-normalised libraries from all non-cancerous tissue types were 
determined (the version of the database used for this was the one available on 2 July 
2009).  This first step was carried out by Andrew Milnthorpe.  Expression thresholds 
were set at 1, 2, 4, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 63, 128 and 256, and 
subsets of genes based on their maximum expression level recorded across all these 
libraries (across all the tissues) were identified.  Statistical relationships between these 
subsets and the previously constructed list of 1,089 genes were identified.  The 
maximum positive correlation value of +0.48 was recorded for the subset of transcripts 
with the maximum EST counts of at least 18 in at least one of the 155 libraries tested.  
That subset contained 909 transcripts, of which 483 were already among the earlier 
found genes (the 1,089 set).  The newly identified 426 transcripts were added to the 
48 
original selection yielding 1,515 UniGene IDs.  These procedures were undertaken by 
Mikhail Soloviev.  Following a more recent update to the version of the database 
available on 18 August 2010, this list was reduced to 1,437 transcripts by excluding 78 
transcripts (due to removal of these entries from the subsequent CGAP database 
release).  Expression levels (EST counts) were then calculated for each of these 1,437 
UniGene clusters for each of the main 26 human tissues matching tissue definitions of 
CGAP database, except for bone marrow, which was combined with bone, its parent 
tissue, and cerebellum and cerebrum, which were combined with brain, of which they 
are dependent tissues.  However, some tissues, e.g. brain and nearby pituitary gland 
were not combined because despite being close together, therefore relevant EST 
libraries were assigned to different tissues.  Also, having a few tissues with only limited 
(often single) suitable EST libraries would not allow the consistent analysis of all 
dependent tissues at many levels of resolution.  To avoid such inconsistency, dependent 
tissues were not analysed.  The produced expression matrix (1,437 transcripts x 26 
tissues) was used for further optimisation.  These procedures were performed by 
Andrew Milnthorpe. 
3.5.2. Optimised selection of UniGene clusters to achieve improved 
tissue-specificity 
The first round of optimisation aimed to reduce inter-tissue correlations.  Tissue-
specific expression "super-libraries" were created for 26 tissues from 126 bulk, non-
normalised libraries made from normal tissues with at least 200 total EST counts, by 
combining EST counts for the selected set of 1,437 transcripts from the same tissue, 
where more than one EST library per tissue was available.  Pearson product-moment 
correlation coefficients were calculated for all pair-wise combinations of such tissue 
specific expression data sets.  The Pearson correlation is invariant to the changes in 
location and scale in the variables, the calculated correlation coefficients yield 
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comparable values within the same scale interval (–1 to +1) for all tissues and libraries 
irrespective of their size, coverage, the number of ESTs or any preceding linear data 
transformations.  This was done using Excel formulae (Zou et al, 2003): 
 
𝐶𝑜𝑟𝑟𝑒𝑙(𝑋, 𝑌) =  
∑(𝑥−𝑚)(𝑦−𝑛)
∑(𝑥−𝑚)2∑(𝑦−𝑛)2
    (3) 
 
Where x and y are the EST count for the transcript concerned in super-libraries X and Y 
respectively, where m and n are the mean EST counts across all 1,437 transcripts in 
super-libraries X and Y, respectively, and where Correl(X,Y) is the calculated Pearson 
Correlation Coefficient between the two super-libraries. 
 
Sum of squared errors was calculated from the deviations of the calculated correlation 
values from 1 as follows: 
 
𝑆 =  ∑(𝐶𝑜𝑟𝑟𝑒𝑙 − 1)2     (4) 
 
Where Correl is the calculated Pearson Correlation coefficient between two super-
libraries and where S is the calculated sum of squares value for the correlations between 
all possible pairs of super-libraries. 
 
These values were used as a measure of discrepancy between the calculated correlation 
data and the model (no inter-tissue correlation of expression data for the selected 
markers).  The change in the inter-tissue correlation values following removal of 
individual cluster expression data from the subset of 1,437 transcripts was then tested.  
The individual transcripts, removal of which had favourable effect on the reduction of 
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the overall inter-tissue correlations were permanently removed and the iterative rounds 
of transcript removal were repeated.  This experiment was undertaken by Andrew 
Milnthorpe.  The best remaining transcripts (the last 505) were used for the second 
optimisation round, which was aimed to improve intra-tissue correlations.  EST counts 
for each of the remaining 505 transcripts for each individual non-normalised library 
from normal (non-cancer) tissues (the same libraries as used before) were compared to 
each other.  This time individual library expression data (not the super-libraries) were 
used to calculate sum of squared differences between the calculated correlation data and 
the model (high intra-tissue correlation of expression data for the tissues where two or 
more individual libraries were available).  The change in intra-tissue correlation values 
was tested following removal of individual cluster expression data from the subset of 
505 clusters.  This step was performed by Andrew Milnthorpe.  After repeating this 
procedure for all of the 505 remaining clusters, all the transcripts were scored and the 
ones, removal of which improved the correlations most were permanently removed.  
244 transcripts were eventually selected as the generic EST expression tissue-specific 
dataset.  This step was performed by Mikhail Soloviev.  The reduced expression matrix 
(244 transcripts x 26 tissues, referred to as EST expression matrix) was used by Andrew 
Milnthorpe for all subsequent analyses. 
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4. Results 
4.1 Problems found to be present in CGAP’s tools during 
creation of the new tools 
4.1.1. Errors in library search algorithm used by CGAP tools 
In the attempt to replicate the cDNA xProfiler and cDNA DGED algorithms it was 
found that the core hierarchical classification system on which both the cDNA xProfiler 
and the cDNA DGED rely is not flawless.  For example a search of cDNA database for 
the "ear" tissue resulted in over 100 libraries of which only six were actually generated 
from ear or related tissues (see Figure 4, database access date 13 May 2010).
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Figure 4. Tissue type origin of libraries reported for by CGAP tools after 
searching for "ear" tissue.  All the libraries reported in this search (database access 
date 13 May 2010) were then manually checked for their "unique tissue" annotations 
and the percentage of the reported libraries which originate from all tissues were 
calculated. 
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The remaining ~94% of the libraries would be from irrelevant tissues such as the heart 
and brain.  Other tissues also contained irrelevant libraries, e.g. brain library pool 
contained nine other unrelated tissues, or if eye libraries were selected, out of the 73 
libraries, five were mixed tissues.  Table 1 reports the correct/incorrect library inclusion 
rates for all other tissue types available and listed on the CGAP server.  We have reason 
to believe that the CGAP library selection algorithms had serious flaws; these are 
detailed below and in Figure 4, using the "ear" library search as an example. 
 
All libraries containing a text string "heart" in their "keywords" field (see Figure 1) 
seem to be included indicating that CGAP search for the correct string "ear" using any 
text matches, regardless of whether that string is part of a longer string such as "heart" 
or is a standalone word (as in ear tissue).  This deficiency also brings into the results 
some libraries whose "unique tissue" field contains "brain", "cerebellum", "cerebrum", 
"thymus" or "vascular" because their "keywords" contain the phrase "heart disease" in 
their "keywords" field.  This results in the inclusion of dependent or irrelevant tissues. 
 
Other heart libraries which do not contain "heart" in their "keywords" field but contain 
"pericardium" instead are still included despite the fact that the letters "ear" do not 
appear in their "keywords" field.  We found these to contain "heart" in their "unique 
tissue" field.  Therefore CGAP must be searching "unique tissue" field similarly to the 
"keywords" fields and erroneously include partial text string matches. 
 
A number of other libraries that contain "kidney" or "ovary" in their "unique tissue" 
field were included.  We identified the reason for these - their "keywords" field contains 
text "clear cell renal carcinoma" or "clear cell ovarian tumor", where a search string 
"ear" can be found in "clear". 
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Table 1.  Error rates for the CGAP library selection tools. 
Tissue types available Number of 
correctly 
reported 
libraries 
Number of 
incorrectly 
reported 
libraries 
Percentage of 
correctly 
reported libraries 
Percentage of 
incorrectly 
reported libraries 
Adipose 18 0 100.00 0.00 
Adrenal cortex 3 0 100.00 0.00 
Adrenal medulla 1 0 100.00 0.00 
Bone 38 77 33.04 66.96 
Bone marrow 54 2 96.43 3.57 
Brain 543 476 53.29 46.71 
Breast/Mammary Gland 1,137 7 99.39 0.61 
Cartilage 24 0 100.00 0.00 
Cerebellum 13 1 92.86 7.14 
Cerebrum 428 2 99.53 0.47 
Cervix 36 0 100.00 0.00 
Colon 974 11 98.88 1.12 
Ear 6 100 5.66 94.34 
Embryonic tissue 43 466 8.45 91.55 
Endocrine 26 437 5.62 94.38 
Eye 44 28 61.11 38.89 
Gastrointestinal tract 48 1,335 3.47 96.53 
Genitourinary system1 0 0 0.00 0.00 
Germ cell 6 46 11.54 88.46 
Head and neck 4 951 0.42 99.58 
Heart 44 41 51.76 48.24 
Kidney 199 12 94.31 5.69 
Limb 0 1 0.00 100.00 
Liver 128 25 83.66 16.34 
Lung 392 11 97.27 2.73 
Lymph node 28 0 100.00 0.00 
Lymphoreticular 16 97 14.16 85.84 
Mammary gland/Breast 1,137 7 99.39 0.61 
Muscle 36 104 25.71 74.29 
Nervous 10 1,072 0.92 99.08 
Oesophagus 21 1 95.45 4.55 
Ovary 188 8 95.92 4.08 
Pancreas 33 16 67.35 32.65 
Pancreatic islet 14 0 100.00 0.00 
Parathyroid 4 3 57.14 42.86 
Peripheral nervous 
system 
6 42 12.50 87.50 
Pineal gland 7 1 87.50 12.50 
Pituitary gland 14 1 93.33 6.67 
Placenta 382 2 99.48 0.52 
Pooled tissue2 Not available Not available Not available Not available 
Prostate  346 9 97.46 2.54 
Retina 23 0 100.00 0.00 
Salivary gland 10 6 62.50 37.50 
Skin 89 11 89.00 11.00 
Soft tissue 2 113 1.74 98.26 
Spleen 22 6 78.57 21.43 
Stem cell 29 57 33.72 66.28 
Stomach 333 21 94.07 5.93 
Synovium 20 0 100.00 0.00 
Testis 222 3 98.67 1.33 
Thymus 39 1 97.50 2.50 
Thyroid 401 10 97.57 2.43 
Uncharacterised tissue 1,959 5 99.75 0.25 
Uterus 255 2 99.22 0.78 
Vascular 34 3 91.89 8.11 
White Blood Cells1 0 0 0.00 0.00 
1 No libraries were present in the database for these tissues 
2 Pooled tissue was not available in the CGAP tools, which listed these libraries under each of the tissues 
they were produced from.
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Another keyword field error for "ear" search was found for libraries whose "unique 
tissue" field contains "uncharacterised tissue".  Under their "keywords" field we found 
text "peripheral blood mononuclear cell" which is an incorrectly match for the search 
string "ear". 
 
Finally, and unexpectedly, libraries created from mixed tissue samples (and therefore 
contain "pooled tissue" in their "unique tissue" field) were still included even if they did 
not contain the ear tissues.  The reason is the same as described above - these libraries 
contained "heart" in their "keywords" field.  In the same manner, as of 25 February 
2012, libraries labelled with multiple tissue preparations, library protocols or tissue 
histologies will appear in the results if one their keywords matches the chosen library 
protocol or tissue preparation. 
 
These errors in CGAP’s library parsing algorithm were corrected once the findings were 
reported to NCBI.  However, when last checked on 25 January 2012, “pooled tissue” 
libraries whose “keywords” field contains the required phrase were still being included 
with the tissue concerned.  For example, a search of the database for “brain” tissue 
resulted in the inclusion of 13 libraries from mixed tissue samples along with the 984 
libraries from brain and its dependent tissues which were correctly reported.  
Furthermore, one library from uncharacterised tissue was included.  The inclusion of 
these mixed tissue libraries is erroneous because their gene expression levels are likely 
to be different from the gene expression levels in brain tissue. 
 
We have also discovered that after correction by NCBI, while the only irrelevant 
libraries included are those from tissue samples labelled as mixed or uncharacterised, 
the inclusion of libraries from any dependent tissues is inconsistent.  We have 
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discovered that bone marrow is not included with bone even though bone marrow is a 
constituent of bone tissue, resulting in the exclusion of 58.7% of the libraries which 
quality for inclusion in the results for bone (Figure 5).  This is despite the fact that other 
dependent tissues are correctly grouped with their parental tissue, for example 
cerebellum and cerebrum are correctly reported alongside brain, of which they are 
constituents. 
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Figure 5. Percentage of libraries qualifying for inclusion under bone tissue by 
CGAP’s tools which originate from bone or bone marrow.  All the libraries reported 
in this search (database access date 26 January 2012) could be reported for inclusion 
when CGAP’s tools are used to search for bone tissue, but only the bone libraries are 
presented. 
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58.70%
bone bone marrow
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4.1.2. Errors in CGAP’s gene search algorithm 
We have also found that the cDNA xProfiler yields different lists of transcripts 
compared to cDNA DGED when all the same parameters are used.  For example when 
normal adipose tissue was compared with cancerous adipose tissue using the cDNA 
xProfiler and the cDNA DGED, 1,359 transcripts were reported by both tools, 150 
additional transcripts were reported by the cDNA xProfiler only and 273 by the cDNA 
DGED only, see Figure 6.  This problem was not limited to this tissue alone.  It was also 
discovered that the xProfiler reports additional transcripts to be present in its summary 
table of transcript results, compared to the transcript lists, see Table 2.  As this table also 
shows, the total number of transcripts reported by cDNA DGED is greater than the 
number reported by the cDNA xProfiler gene lists and less than the number reported by 
the cDNA xProfiler results table.  An attempt was made to analyse these discrepancies 
by looking into transcript annotations for the transcripts which were listed incorrectly, 
i.e. not listed by both tools. 
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Figure 6. Differences in the number of transcripts reported by CGAP tools for an 
identical query.  The total number of transcripts reported to be present when normal 
adipose libraries (in one pool) are compared with cancerous bone libraries (in the other 
pool) by the cDNA xProfiler’s transcript lists (left circle) and the cDNA DGED (right 
circle).  The overlap between the two circles represents the transcripts reported by both 
tools. 
cDNA xProfiler
150
cDNA DGED
273
Both 
tools 
1,359 
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Table 2.  Number of transcripts reported to be present in both pools when normal 
adipose libraries (in one pool) were compared with cancerous adipose tissues (in the 
other pool), by the cDNA xProfiler’s transcripts lists and summary table of results, and 
by the cDNA DGED. 
Tool and output method used Number of transcripts reported 
cDNA xProfiler results table 1,688 
cDNA xProfiler gene lists 1,509 
cDNA DGED 1,632 
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The correct list of transcripts to report for this particular comparison of normal adipose 
tissue with cancerous adipose tissue should include both the 1,359 transcripts reported 
by both tools and the 273 transcripts reported only by cDNA DGED.  Both our 
transcript search routine and CGAP DGED appear to produce correct gene lists whilst 
the cDNA xProfiler missed 273 transcripts and also incorrectly selected 150 transcripts.  
This is because the cDNA DGED accesses the publically available CGAP relational 
database using the same method as our algorithm (see section 3.3.2 in the Methods 
section, entitled "Creation of novel transcript search algorithms to resolve issue of 
different transcript lists being reported by CGAP") to find transcripts which are 
represented by ESTs in one or more of the libraries presented in each pool, whilst the 
cDNA xProfiler accesses a single-file database which appears to miss 273 transcripts 
from the presented libraries and also incorrectly lists as being present in the chosen 
libraries the 150 additional transcripts.  This discovery was confirmed by closer 
inspection of the results for the comparison of normal and cancerous bone libraries 
shown in Table 3, which revealed that the cDNA xProfiler reported 237 additional 
transcripts not reported by the cDNA DGED, while 707 of the genes reported by the 
cDNA DGED were omitted from the cDNA xProfiler’s results. 
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Table 3. Number of transcripts reported to be present in either or both pools when 
normal bone libraries (in one pool) are compared with cancerous bone libraries (in the 
other pool) by the cDNA xProfiler’s transcripts lists and summary table of results, the 
cDNA DGED and using the new algorithm. 
Tool and output method used Number of transcripts 
reported 
Reporting the presence or absence of each gene in a Boolean manner 
cDNA xProfiler results table 10,108 
Our algorithm  9,996 
Reporting the sequence odds ratio for each gene 
cDNA DGED 9,996 
Our algorithm  9,996 
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These problems were corrected once the findings were reported to NCBI.  However, 
subsequently we have discovered the inclusion of some libraries such as the brain 
library “NIH_MGC_181” in some searches where known, unknown, unique and non-
unique transcripts are all reported (for example, normal brain vs. cancerous brain) will 
cause discrepancies in the distinguishing of transcripts as unique or non-unique.  While 
some transcripts that are found in both pools (one in this case) are correctly reported as 
non-unique (found in at least one library outside the two pools) in the lists for each of 
the two pools (which list the transcripts in the relevant pool regardless of whether they 
are also found in the other pool), the transcripts concerned are incorrectly reported as 
unique (found only within the libraries included in the pools) in the lists of transcripts 
found in both pools.  It was also discovered that the pooled tissue library 
“NIH_MGC_184” causes this problem when included with endocrine tissue, but does 
not cause this problem with brain. 
 
As Table 4 shows for brain, this problem causes the number of unknown, non-unique 
transcripts reported as being present in both pools to not match what would be 
calculated from the figure reported for each pool on its own and the figures for each 
pool including transcripts common to both (this can be seen with the two columns 
representing unknown transcripts).  Table 5 presents the figures that would be displayed 
if the results were reported correctly.  In the internally available flat file database 
accessed by the cDNA xProfiler, the transcripts listed for each library are categorised 
according to whether they are unique to that library, so it appears that the cDNA 
xProfiler is incorrectly processing this information and misreporting some transcripts as 
unique when they are in fact non-unique. 
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Table 4.  Numbers of known, unknown, unique and non-unique transcripts reported to 
be present in either or both pools when normal brain libraries (in pool A) are compared 
with cancerous brain libraries (in pool B) by CGAP’s cDNA xProfiler. 
Subset Known 
unique 
transcripts 
Unknown 
unique 
transcripts 
Known 
non-
unique 
transcripts 
Unknown 
non-unique 
transcripts 
Total 
A 6 425 9,514 2,260 12,205 
B 2 201 7,912 1,327 9,442 
A or B 8 627 11,674 3,239 15,548 
A and B 0 1 5,752 346 6,099 
A minus B 6 425 3,762 1,913 6,106 
B minus A 2 201 2,160 980 3,343 
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Table 5.  Numbers of known, unknown, unique and non-unique transcripts which 
should be reported for either or both pools when CGAP’s cDNA xProfiler is used to 
compare normal brain libraries (in pool A) with cancerous brain libraries (in pool B). 
Subset Known 
unique 
transcripts 
Unknown 
unique 
transcripts 
Known 
non-
unique 
transcripts 
Unknown 
non-unique 
transcripts 
Total 
A 6 425 9,514 2,260 12,205 
B 2 201 7,912 1,327 9,442 
A or B 8 626 11,674 3,240 15,548 
A and B 0 0 5,752 347 6,099 
A minus B 6 425 3,762 1,913 6,106 
B minus A 2 201 2,160 980 3,343 
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This problem occurred for brain, endocrine, gastrointestinal tract, nervous, pancreas and 
thyroid.  However, when last checked on 27 June 2012, this problem only occurred for 
nervous and pancreas.  This suggests that while the cDNA xProfiler now reports the 
correct results for most libraries, some problems still remain. 
4.1.3. CGAP errors in estimating significance of the predicted value 
of gene overexpression 
The False Discovery “Q” values are used to indicate the likelihood of each expression 
result being a false discovery.  These values are reported by the cDNA DGED and are 
based on Benjamini-Hochberg statistics and the Fisher Exact Test. 
 
The value “Q” should indicate the reliability of the calculated odds ratio “F”.  It was 
found that the “Q” value calculated by CGAP DGED would change depending on the 
user-selected display cut-off for the odds ratio “F”.  This is certainly incorrect, as the 
probability of finding upregulation should not depend on whether a whole list of 
transcripts or part of that list is looked at.  We believe that the probability of the result 
being correct should not depend on the display cut-off setting (all three are upregulated 
more than twofold).  Table 6 illustrates this for three distinct entries.  All the “Q” values 
are reported as very close to zero which indicates statistically very significant results.  
However, if the display cut-off is increased from two to three, the “Q” values for all 
three results change, indicating apparently increased statistical significance, which is not 
the case. 
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Table 6. Change in probability values reported by the cDNA DGED and the new 
algorithm when the display cut-off value "F" is changed are exemplified for three 
transcripts that are presented in the results list when normal bone libraries are compared 
with cancerous bone libraries. 
UniGene 
Cluster ID 
Name Symbol 
CGAP "Q" values1 
The new "P" 
values2 
"F" = 2 "F" = 3 "F" = 2 "F" = 3 
280130 
Ribosomal 
protein S24 
RPS24 1.10x10-10 1.05x10-10 1.23x10-13 1.23x10-13 
172928 
Collagen, type I, 
alpha 1 
COL1A1 3.15x10-44 2.98x10-44 2.70x10-48 2.70x10-48 
436568 
CD74 molecule, 
major 
histocompatibility 
complex, class II 
invariant chain 
CD74 9.37x10-20 8.88x10-20 6.73x10-9 6.73x10-9 
1 Calculated using online tools from CGAP; calculations based on equations (1 and 2) in this report). The 
calculated "Q" value is close to zero (on a scale of zero to one) if the probability is high that the observed 
expression difference is genuinely greater than the user-specified "F" value, and is not a false discovery 
(Benjamini and Hochberg, 1995). 
2 Calculated using equation (1) in this report. This produces a "P" value of between zero and one.  The 
calculated “P” value is close to zero (on a scale of zero to one) if the probability is high of the observed 
expression difference being genuine and not due to sampling error, in the manner of a Chi-Squared “P” 
value (Daya, 2002; Yousef et al, 2004). 
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4.1.4. CGAP incorrectly calculates number of ESTs per library and 
includes empty and missing entries in their database 
We believe that the number of ESTs in each library is an indirect indicator of the library 
quality because a library containing only a few ESTs is less likely to provide a 
representative picture of gene expression in the sample from which it was created than a 
library in which many ESTs map onto transcripts.  As Table 7 shows, when normal 
adipose tissue was compared with cancerous adipose tissue using cDNA DGED, it was 
discovered that the sum of the number of ESTs in each library based on the annotations 
in the library database (in the "sequences" field, see Figure 1) was always greater than 
the number of ESTs cDNA DGED reported to be mapped onto all the transcripts in each 
pool (cDNA DGED uses the latter for its statistical tests, more on these below).  This 
problem is not limited to adipose tissue and it affects the majority of the library 
database. 
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Table 7. Total number of ESTs reported for normal adipose tissue libraries and for 
cancerous adipose tissue by cDNA DGED library list and transcript list. 
Results list ESTs in normal 
adipose libraries 
ESTs in cancerous 
adipose libraries 
Library list 2,285 1,740 
Transcript list 1,799 721 
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Despite reporting these findings to NCBI, we have discovered that this problem still 
exists.  It has also been discovered that the library entitled “SARS-Cov infected lung 
tissue” has an incorrect “sequences” annotation of zero, suggesting it is an empty library 
(more on these below, see section entitled “CGAP incorrectly lists libraries which do 
not contain any transcript-mapping ESTs”).  However, when the number of ESTs 
mapping onto the transcripts in each library was calculated (see section 4.2.4 below 
entitled “Solution to the problem with number of sequences per library and erroneous 
inclusion of empty of missing database entries”), it was discovered that this library 
contained 1,083 ESTs which mapped onto 1,023 transcripts.  When last checked on 26 
January 2012 the CGAP tools were found to misreport this library as containing no 
ESTs, potentially leading to its omission from a search, removing potentially useful 
gene expression data from the results and leading to the omission of potentially valid 
biomarkers or targets from further study or the study of false positive results in further 
investigations. 
 
We have also discovered that the expression data file of the relational database used by 
cDNA DGED contains information for 37 libraries which are not listed in the library 
data file, in addition to the 8,378 libraries for which there is expression data (more on 
this below).  As a result of this error the additional libraries will never be reported in 
any searches and the 3,846 expression data records they refer to (in which a total of 
7,805 ESTs map onto 2,919 transcripts (all of which were also found in the 8,378 
libraries in the library list) will never be of use to any study, leading to the omission of 
potentially valid biomarkers or targets from further investigation or the inclusion of 
false positive results in further experiments. 
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In addition to the 8,378 libraries which contain transcript-mapping ESTs (these are the 
8,378 also presented in the expression database as mentioned above), the CGAP library 
database has been found to contain 529 libraries which do not contain any tags that map 
onto transcripts, of which 164 are annotated as SAGE (these are the only SAGE 
libraries in the database).  Thus 5.94% of the libraries contain no expression 
information, as demonstrated in Figure 7.  Of these, 228 libraries, including all those 
annotated as SAGE, do not contain any tags at all according to their “sequences” 
property.  This is certainly incorrect because these libraries contain no expression data 
and their inclusion in a search will provide no contribution towards the results of any 
study. 
 
Similarly the transcript database contains 3,202 transcripts (2.59% of the total) which 
do not map onto any ESTs in any libraries, as presented in Figure 8.  This is an error 
because this database is not intended to be a transcript catalogue and is instead intended 
for use in gene expression profiling investigations.  These transcripts will not appear in 
any results and will therefore not be further studied. 
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Figure 7. Percentage and number of libraries in CGAP’s database which do not 
contain any expression information.  All the libraries in CGAP’s library database are 
presented in this pie chart, which shows the fraction of the libraries which do not 
contain any expression information (no ESTs or SAGE tags mapping onto any 
transcripts) and which therefore serve no purpose in any investigations. 
164, 1.84% 365, 4.10%
8,378, 94.06%
SAGE Libraries (all with no transcript-mapping SAGE tags)
EST Libraries with no sequences ESTs mapping onto transcripts
EST Libraries containing at least one transcript-mapping ESTs
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Figure 8. Percentage and number of mapped and unmapped transcripts in 
CGAP’s database.  All the genes in CGAP’s gene database are shown in this pie chart, 
which shows the fraction which do not map onto any ESTs in any libraries (the 
unmapped fraction) and which therefore will never be reported in any study. 
3,202, 2.59%
120,257, 
97.41%
Unmapped transcripts Mapped transcripts
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4.2.   Solutions to CGAP errors implemented in new tools 
In the attempt to identify the causes of errors and to further improve CGAP’s cDNA 
xProfiler and cDNA DGED algorithms, the library and transcript parsing algorithms 
were studied by recreating them using Microsoft Excel.  Revisions were then 
implemented to rectify the errors detailed above. 
4.2.1. Solution to the errors in the library search algorithm 
A library parsing algorithm has been designed to search only for the exact tissue type in 
each library’s "unique tissue" field.  For example, if ear is selected, we select libraries 
which only contain the exact string "ear" in this field and which do not have any other 
annotations in this field, resulting in the selection of libraries from the chosen tissue 
type without the inclusion of libraries from irrelevant tissues.  Dependent tissues are 
also excluded, if the user chooses not to display them (see below). 
 
If the required phrase is part of a longer phrase in a library’s annotation (for example the 
phrase "bone" is part of the "bone marrow" annotation in the "unique" tissue field of a 
bone marrow library), the library with the longer phrase is ignored and not included in 
the results.  In this example the selection would only contain bone libraries and not 
include bone marrow libraries.  The recreated algorithm does this by searching for the 
required phrase as the only annotation in the "unique tissue" field, which does not 
contain any information other than the correct tissue type annotation for each library 
and therefore does not select dependent or irrelevant tissues.  Furthermore, the recreated 
tool lists “pooled tissue” libraries as a separate user-selectable tissue type and does not 
include these libraries in the results for any other tissue, even if their “keywords” field 
contains the required phrase for the chosen tissue.  This means that the results obtained 
will be based solely on libraries from the chosen tissue and will not be due to the 
75 
inclusion of mixed tissue libraries.  In the same way, libraries created from multiple 
tissue preparations or histologies or made using multiple library protocols are presented 
under separate user-selectable settings instead of being included when one of their 
keywords matches another setting.  The recreated algorithm is also consistent about the 
inclusion of libraries from dependent tissues in the results, and allows the user control 
over whether such libraries are presented or not, something which is not possible with 
the CGAP algorithms.  As a result, if the user chooses to display libraries from 
dependent tissues and chooses to search for bone tissue in at least one pool, both bone 
and bone marrow libraries will be reported in the pool(s) concerned, and therefore both 
sets of libraries presented in Figure 5 will be displayed. 
4.2.2. Solution to the errors in the gene search algorithm 
Two transcript parsing algorithms have been devised which search the CGAP relational 
database (as does the cDNA DGED) for transcripts contained within the presented 
libraries.  One reports the expression information for each transcript as a Boolean type 
result identifying the presence or absence of a transcript in a pool (as does the cDNA 
xProfiler), while the other calculates an EST odds ratio for each individual transcript.  
Both report the results as a single list of all the transcript present in at least one pool 
along with the expression information.  As Table 3 shows, these algorithms report the 
same transcript counts.  The cDNA DGED reports the same transcript count for the 
same set of libraries whilst the cDNA xProfiler does not. 
 
The recreated cDNA xProfiler-type algorithm avoids the problem of misreporting non-
unique transcripts as unique by searching the publically available relational database, 
which does not present this information.  However the availability of multiple pools by 
the recreated algorithm makes it possible to elucidate whether a transcript is unique to 
the libraries included using the recreated algorithm.  This would be achieved by setting 
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up an additional pool containing all libraries from the database except for those in the 
other pools. 
4.2.3. Correct way to estimate the significance of the calculated gene 
expression 
Though CGAP’s statistics could not be completely implemented, the CGAP problem of 
apparent statistical significance changing after changing the display value “F” was 
solved by the implementation of only the Fisher Exact Test from which CGAP’s “Q” 
values are calculated.  As Table 6 shows, the resulting “P” values are the same 
regardless of the “F” display cut-off.  That method calculates the probability of 
obtaining by chance the observed expression difference for a transcript between the two 
pools, using Equation (1) in section 3.3.3. 
4.2.4. Solution to the problem with number of sequences per library 
and erroneous inclusion of empty or missing database entries 
The problem of ESTs being reported by CGAP tools for each library which did not map 
onto the UniGene transcripts within that library was solved.  The number of ESTs in 
each library which map onto the transcripts reported for that library was calculated, and 
this information was added to the library database for reporting in the list of libraries.  
The library parsing algorithm uses this calculated number instead of the "sequences" 
figure submitted by the library creator and included in the database by CGAP.  This 
new approach reports the same total for the number of libraries in each pool as it does 
for the number of ESTs which map onto the transcripts in that pool (Table 8).  This 
approach also means that the library entitled “SARS-Cov infected lung tissue” is 
correctly reported as containing 1,083 ESTs which map onto 1,023 transcripts, allowing 
it to be included in any study in which the sequences filter is used to only display high 
quality libraries with, for example, at least 1,000 transcript-mapping ESTs. 
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Table 8. Total number of ESTs reported for normal bone libraries and for cancerous 
bone libraries by the library list and transcript list produced by the CGAP tools and by 
the new routine. 
Number of ESTs reported 
ESTs reported for 
normal bone 
libraries 
ESTs reported for 
cancerous bone 
libraries 
Library list from CGAP tools 19,308 18,197 
Transcript list from cDNA DGED 17,844 16,635 
Library list from our new algorithm 17,844 16,635 
Transcript list from our new 
algorithm 
17,844 16,635 
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The problem of libraries being included in CGAP’s expression database which are not 
included in the library database was solved by removing the expression data records 
concerned from the copy of the relational database used by the recreated tools.  This has 
the added advantage of reducing the time required for a search.  Therefore, expression 
data is only present in the copy used by the recreated algorithm for the libraries that are 
found in both files, with data for the missing libraries deleted. 
 
The problem of the inclusion of libraries containing no transcript-mapping ESTs was 
solved by the removal of these libraries from the copy of the library database used by 
the recreated algorithms, leaving only the libraries which contain transcript-mapping 
ESTs.  This also provided a decrease in search time.  As a consequence of this, the only 
libraries found in the library database used by the recreated algorithm are the libraries 
presented in Figure 7 as containing transcript-mapping ESTs. 
 
Similarly the transcripts which were found to not map onto any ESTs in any libraries 
were also removed because the purpose of the database is for gene expression profiling 
and not as a transcript catalogue.  This also reduces the time needed for an investigation.  
Therefore the copy of the database used by the recreated algorithm contains only the 
transcripts which are shown by Figure 8 to be found in at least one library. 
4.3. Further improvements made to new tools 
In addition to the solutions to the errors in the online tools detailed above, the key 
improvement in the recreated tools is the provision of more than two pools.  The tools 
are designed to accommodate any number of pools up to and including the maximum of 
8,192 pools.  Because each pool requires two columns this is the maximum capacity of 
an Excel 2007/2010 worksheet.  This enables the finding of transcripts in a specific 
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tissue which are not expressed in unrelated tissues, but which are expressed in tissues 
that are connected or located nearby, for example: 
 
𝑡ℎ𝑦𝑟𝑜𝑖𝑑 𝑁𝑂𝑇 
(
 
 
 
 
 
 
𝑝𝑎𝑟𝑎𝑡ℎ𝑦𝑟𝑜𝑖𝑑
𝑂𝑅
𝑣𝑎𝑠𝑐𝑢𝑙𝑎𝑟
𝑂𝑅
𝑃𝑁𝑆
𝑂𝑅
𝑜𝑒𝑠𝑜𝑝ℎ𝑎𝑔𝑢𝑠
𝑂𝑅
𝑚𝑢𝑠𝑐𝑙𝑒 )
 
 
 
 
 
 
     (5) 
 
Where PNS refers to the peripheral nervous system. 
 
This six-pool search would present a list of transcripts which are expressed only in the 
thyroid and not in the parathyroid, oesophagus or muscles which are nearby.  The 
reported transcripts would also not be expressed in the peripheral nervous system or the 
vasculature, which innervate and vascularise the thyroid, respectively. 
 
This feature can also be used to find transcripts which are found only in a specific organ 
and not within any other organs in the same organ system, as well as being absent from 
unrelated tissues which are connected or proximal.  For example: 
 
(
 
 
𝑘𝑖𝑑𝑛𝑒𝑦
𝑂𝑅
𝑎𝑑𝑟𝑒𝑛𝑎𝑙 𝑚𝑒𝑑𝑢𝑙𝑙𝑎
𝑂𝑅
𝑎𝑑𝑟𝑒𝑛𝑎𝑙 𝑐𝑜𝑟𝑡𝑒𝑥 )
 
 
 𝑁𝑂𝑇 
(
 
 
 
 
𝑒𝑛𝑑𝑜𝑐𝑟𝑖𝑛𝑒
𝑂𝑅
𝑏𝑙𝑎𝑑𝑑𝑒𝑟
𝑂𝑅
𝑃𝑁𝑆
𝑂𝑅
𝑣𝑎𝑠𝑐𝑢𝑙𝑎𝑟 )
 
 
 
 
    (6) 
 
Where PNS refers to the peripheral nervous system. 
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This search requires 7 pools and would provide a list of transcripts which are only found 
in the kidney or its two outer layers (the adrenal medulla and adrenal cortex) and not in 
the blood vessels in this vascularised organ, or in the bladder (elsewhere in the urinary 
system) or other glands of the endocrine system. 
 
The above queries could be extended to produce a list of transcripts which are only 
found in specific types of cancer that are associated with the organ of interested.  For 
example: 
 
𝑝𝑎𝑝𝑖𝑙𝑙𝑎𝑟𝑦 𝑡ℎ𝑦𝑟𝑜𝑖𝑑 𝑐𝑎𝑟𝑐𝑖𝑛𝑜𝑚𝑎 𝑁𝑂𝑇 
(
 
 
 
 
 
 
 
 
𝑚𝑒𝑑𝑢𝑙𝑙𝑎𝑟𝑦 𝑡ℎ𝑦𝑟𝑜𝑖𝑑 𝑐𝑎𝑟𝑐𝑖𝑛𝑜𝑚𝑎
𝑂𝑅
𝑡ℎ𝑦𝑟𝑜𝑖𝑑
𝑁𝑂𝑇
(
 
 
 
 
𝑝𝑎𝑟𝑎𝑡ℎ𝑦𝑟𝑜𝑖𝑑
𝑂𝑅
𝑃𝑁𝑆
𝑂𝑅
𝑜𝑒𝑠𝑝ℎ𝑎𝑔𝑢𝑠
𝑂𝑅
𝑚𝑢𝑠𝑐𝑙𝑒 )
 
 
 
 
)
 
 
 
 
 
 
 
 
 (7) 
 
Where PNS refers to the peripheral nervous system. 
 
This search, which would require 7 pools, would present a list of transcripts which are 
only expressed in papillary thyroid carcinoma and which are not reported for medullary 
thyroid carcinoma or in any of the normal tissues listed. 
 
When choosing options at the beginning of a search the facility is available for libraries 
whose tissue preparation, library protocol and/or tissue histology is annotated as mixed 
or uncharacterised, to be studied separately from other libraries.  There is a major need 
for this when choosing between library protocols.  The multiple preparation, protocol 
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and histology libraries are presented by the CGAP algorithms if one of their keywords 
matches another chosen setting.  However, the uncharacterised libraries are only shown 
if no choice is made so that all libraries are included. 
 
Similarly, libraries which are not annotated as CGAP, MGC or ORESTES or which are 
annotated as belonging to more than one of these groups can be selected separately 
using the recreated algorithm.  This is unlike the CGAP tools where these libraries are 
only included if the list is not filtered according to library group or, in the case of the 
multiple group libraries, one of the groups they belong to is selected. 
 
There is also the provision for the user to filter the libraries by developmental stage.  If 
the aim is to study adult tissue only, this would enable, for example, libraries labelled as 
“embryo”, “infant” or “pediatric” to be excluded.   This would be useful because it is 
known that during these stages genes are expressed which are implicated in growth and 
development, some of which may also be expressed in cancer.  Therefore, use of only 
adult libraries in this situation will not lead to these genes being erroneously excluded 
from further investigation as potential tumour markers. 
 
The new tools incorporate a filter that allows the user to display only the libraries which 
are annotated with a specific gender.  This is because the gene expression levels in 
cancer may be different in each gender and the user may desire to study cancer only in 
males or females. 
 
There is also the facility for filtering the library list according to whether the library is 
annotated as being from a pregnant individual or not.  This will enable the user to 
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exclude libraries from individuals who are pregnant because the gene expression levels 
will be altered in this state. 
 
If the user chooses to search for a library name in either pool, the CGAP tools report all 
libraries whose names contain the specified search string.  For example, if “aorta 
endothelial cells” is entered, two libraries, one with that exact name and the other 
named “Aorta endothelial cells, TNF alpha-treated”, would be presented.  Because these 
libraries are expected to present different gene expression profiles, the new tools also 
allow the user to select whether an exact or partial match is required. 
 
In addition to the availability of a filter based on the minimum library size, there is also 
the ability to exclude libraries whose maximum EST count exceeds a specified value.  
This would enable libraries of a similar size to be presented without the inclusion of, for 
example, one much larger library which may skew the results.  If the two thresholds are 
set to values which are close to one another in magnitude, it is easier to determine the 
tissue coverage (and therefore the reliability) of the results for each pool from the 
number of libraries in that pool. 
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Using the algorithm based on CGAP’s cDNA xProfiler tool, it is possible to filter the 
transcript list according to user-specified criteria.  This can either be done manually 
using Excel’s filter command to filter the columns, or, if no more than four pools are 
involved, can be done automatically by entering the pools into the provided formula.  
This formula is: 
 
(𝑃1(
𝐴𝑁𝐷
𝑂𝑅
𝑁𝑂𝑇
)𝑃2)(
𝐴𝑁𝐷
𝑂𝑅
𝑁𝑂𝑇
)(𝑃3(
𝐴𝑁𝐷
𝑂𝑅
𝑁𝑂𝑇
)𝑃4)   (8) 
 
Where P1, P2, P3 and P4 are four pools.  The user can choose which pools these refer 
to. 
 
When the above facility is used, a list of transcripts is produced matching the chosen 
settings with the pools shown in which each transcript is found.  A results table is also 
produced similar to the one CGAP’s cDNA xProfiler produces, but referring to the 
filtered list. 
 
The algorithm designed to replicate CGAP’s cDNA DGED also provides improvements 
on the functionality of that tool.  Two collections of libraries are compared, each created 
using a formula identical to Equation (8).  This enables up to eight pools to be compared 
at once, enabling queries such as those shown at the beginning of this section to be 
undertaken.  The odds ratio is calculated between the two collections as follows: 
 
(
𝐸𝑆𝑇𝑠 𝑚𝑎𝑝𝑝𝑖𝑛𝑔 𝑜𝑛𝑡𝑜 𝑡𝑟𝑎𝑛𝑠𝑐𝑟𝑖𝑝𝑡 𝑖𝑛 𝐶𝑜𝑙𝑙𝑒𝑐𝑡𝑖𝑜𝑛 1
𝑇𝑜𝑡𝑎𝑙 𝐸𝑆𝑇𝑠 𝑖𝑛 𝐶𝑜𝑙𝑙𝑒𝑐𝑡𝑖𝑜𝑛 1
)
(
𝐸𝑆𝑇𝑠 𝑚𝑎𝑝𝑝𝑖𝑛𝑔 𝑜𝑛𝑡𝑜 𝑡𝑟𝑎𝑛𝑠𝑐𝑟𝑖𝑝𝑡 𝑖𝑛 𝐶𝑜𝑙𝑙𝑒𝑐𝑡𝑖𝑜𝑛 2
𝑇𝑜𝑡𝑎𝑙 𝐸𝑆𝑇𝑠 𝑖𝑛 𝐶𝑜𝑙𝑙𝑒𝑐𝑡𝑖𝑜𝑛 2
)
              (9) 
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In addition to the CGAP functionality, the Excel-based algorithm also presents the name 
of each library that a transcript is reported in and the percentage expression within that 
library.  This allows the consistency of expression within those libraries to be verified.  
The tool also allows only known or unknown genes to be displayed, if that is required. 
4.4. Creation of a procedure for the quality control of gene 
expression data 
In addition to the improvements made to the search algorithms and the correction of 
errors therein, experiments were also carried out with a view to providing a means to 
quality control the expression data itself without reference to any other source of 
information.  It has been hypothesised that if a list of tissue-specific markers could be 
produced the expression levels of the transcripts in that list in libraries of known 
identity could be used as a quality control method by enabling the elucidation of the true 
tissue type of a library. 
4.4.1. Tissue specific transcripts and EST expression matrix 
It was hypothesised that to be suitable for the role of universal tissue specific markers, 
the transcripts should be (i) highly abundant in their target tissues relative to all the 
other tissues and (ii) should be abundant in absolute terms in target tissues.  The high 
relative abundance (high odds ratio) defines the tissue specificity.  The high absolute 
abundance (above 0.1%) was chosen to ensure that such transcripts would still be found 
even in smaller libraries with small number of total EST counts.  Up to thirty individual 
transcripts were eventually selected using criteria described in the Methods section, 
from each of the individual tissue types.  Of the 1,089 transcripts identified, 1,044 were 
present in normal (non-cancer) tissues (although non-exclusively) and 479 originated 
from more than one tissue type.  Whilst that was allowed, a further optimisation of the 
selected subset was necessary. 
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For the majority of the tissues, the original selection was made based on the very small 
number of libraries available in CGAP for those tissues (typically 2-4 libraries, with 
brain and placenta being exceptions where more than 10 libraries were available).  
Because of that and also because of the stringent selection requirements, it was 
reasonable to assume that some suitable transcripts could have been omitted because of 
the very limited choice of libraries available for the analysis and not because of them 
being unsuitable tissue markers.  Therefore, a search was undertaken for additional 
candidate transcripts by looking solely into individual EST counts for all of the 37,575 
different transcripts from 155 non-normalised libraries from all non-cancerous tissue 
types.  Following the procedures outlined in the Methods section the list of potential 
tissue markers was expanded to include 1,437 transcripts. 
 
Because of the relaxed criteria used for selecting the potential tissue markers, and in 
order to find the best makers and also to reduce the list to a more manageable size, an 
attempt was made to optimise the selection using new selection criteria independent of 
the ones used in the original rounds of selection.  For this first round the EST counts for 
the 1,437 transcripts were summed together from all the libraries in each tissue to make 
a super-library for that tissue.  All possible Pearson correlations were calculated 
between all of such super-libraries (Equation (3)).  A higher correlation value here 
means higher inter-tissue correlation and is undesirable; ideally all such inter-tissue 
correlations should be equal to "0".  Hence we calculated sum of squares of deviations 
of the calculated correlation value from "1" (Equation (4)). 
 
Individual genes were then removed and the correlation values and the equation (2) total 
were recalculated.  The gene, whose removal resulted in the lowest overall inter-tissue 
correlations (as calculated per equation (2)) was permanently removed and the iteration 
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steps were repeated again.  The decrease in inter-tissue correlations slowed shortly 
before the 1,000th gene was removed (this was discovered by expanding Figure 9).  The 
remaining 505 genes included the set of high-quality tissue-specific markers and these 
were retained.  A similar optimisation was then repeated for the remaining 505 genes 
but this time the aim was to improve intra-tissue correlations between the individual 
libraries from within the same tissues and hence used the original individual EST 
libraries, rather than the super libraries.  Transcripts were removed one by one and the 
correlations recalculated.  The transcript whose removal resulted in the improvement of 
intra-tissue correlation was permanently removed.  The finally optimised set of tissue-
specific markers contained 244 transcripts for which EST expression matrix (244 
transcripts x 26 tissues) was created.
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Figure 9. Inter-tissue correlation during optimization of marker list for genes with improved tissue specificity.  The increase in the sum of 
squares value (which corresponds to a decrease in the inter-tissue correlation) (y-axis) is plotted against the gene removal iteration (x-axis), after each 
of which the gene was permanently removed whose temporary removal had produced the greatest improvement in the tissue-specificity of the gene list. 
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4.4.2. Inter-tissue correlations and intra-tissue correlations using 
EST expression matrix 
Correlation values between tissue expression profiles of the 244 transcripts from the 
EST expression matrix and the relevant EST counts from 113 largest libraries 
representing 26 main human tissues were calculated.  The correlation data fell into three 
main categories.  The first group contained groups of libraries for which virtually no 
inter-tissue correlation was found, and where all the libraries shown good positive 
correlation (values ranging approximately within +0.2 to +1) with the relevant source 
tissues but not with any of the other tissues.  Figure 10 summarises the results for five 
such representative tissues where correlation levels clearly confirm the identity of each 
of the individual EST libraries.  The second group contained tissues for which only one 
or two non-normalised bulk EST libraries were available.  In the former case (one 
library per tissue) positive correlations of +1 were expected, because for these tissues 
only the EST matrix was based on those expression data.  Nevertheless, no other tissues 
having positive correlation above ~0.2 were identified, confirming the absence of cross-
tissue correlations for the EST matrix entries (Figure 11).  The third group included 
tissues with some degree of multiple tissue positive correlations.  These were brain 
tissue libraries which shown partial positive correlation with peripheral nervous system 
EST libraries, the peripheral nervous system libraries showed a degree of positive 
correlation with brain derived libraries, heart libraries showed weak positive correlation 
with muscle libraries and muscle libraries shown some positive correlation with heart 
libraries (Figure 12).  Some positive correlation between these groups of libraries is 
likely because of the very similar nature of those tissues.  But this was unexpected, 
because one of the original optimisation rounds specifically aimed to exclude such 
correlation where possible.  However such partial positive correlation proves that the 
EST matrix is also capable of identifying more distant but related tissue types.  One 
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particular brain library out of the 13 brain libraries tested (NIH_MGC_181) showed 
unexpectedly high correlation with pituitary gland.  This was much stronger than with 
the brain expression pattern from the EST expression matrix – the supposed origin of 
this particular library (Figure 12A).  A plausible explanation might be an unintentional 
inclusion of pituitary gland tissue with the brain tissues for the original library 
preparation; this is likely due to the close proximity of pituitary gland which is located 
at the base of the midbrain.  Despite the inclusion of this library in the original selection 
and into the subsequent optimisation steps as "brain" derived, the EST matrix was still 
able to pick this inaccurately annotated library, thus confirming the robustness of the 
approach to cluster selection for the EST expression matrix.  Using just tissue-
specificity (the traditional approach which relies on comparing gene expression between 
tissues) would have counted such pituitary library as brain derived, which would have 
influenced the selection of "tissue specific" genes, for which incorrect tissue specificity 
would have been assigned. 
 
Figure 13A summarises the correlation ranges for all the expected matching tissues, 
including the tissues detailed in Figures 10, 11 and 12.  The first and third quartiles for 
all the positively correlated libraries from all tissues studied are 0.4 and 0.8 respectively 
(full range 0.2 to 1).  The negative inter-tissue correlations are shown in Figure 13B.  
These values are based on all of the non-matching inter-tissue correlations, with first 
and third quartile values of –0.04 and –0.02 respectively.  The expected inter-tissue 
correlations (such as brain with peripheral nervous system and heart with muscle) are 
summarised in Figure 13C.  These correlations values are lower than the tissue-specific 
intra-tissue matches (Figure 13A), but notably higher than correlations between any 
non-matching tissues (Figure 13B), with the first and third quartiles at ~0 and +0.14 
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respectively.  Figure 13D compares all three correlations ranges for all cases (positive 
tissue matches, related tissues, and non-matching tissues). 
 
In order to systematically investigate the robustness of this approach to quality control, 
modelled EST data were used to simulate small EST expression datasets.  These were 
generated from the reported EST expression data taken from CGAP database, by 
proportionally reducing the reported EST counts and rounding any fractional values to 
the nearest whole EST count each time until each library ceased to present any ESTs 
mapping onto the 244 marker transcripts or ceased to be identified as a positive tissue 
match for the tissue from which it was created in the first place.  Using this approach 
the real EST expression data were gradually scaled down and all of the generated model 
libraries were compared with the original libraries including from all other tissues by 
calculating the correlation values for the 244 UniGene IDs from the optimised matrix 
set (Figure 14 – Figure 18).  Virtually every library continued to correlate well with the 
tissue of origin until the very last EST mapping onto one of the transcripts in the matrix 
is removed.  Furthermore, the majority of the scaled down libraries remain identifiable 
until the total library EST counts falls below the range of 10 to 50, which is equal to 
some of the smallest libraries currently in the CGAP database.  Remarkably, some of 
the libraries remain identifiable when the libraries are scaled down to 0.5% of their 
original size.  This shows that the EST matrix can be used to characterise small libraries 
despite the fact that they are less representative due to the reduced likelihood of rare 
transcripts being included in such libraries. 
 
These results are summarised in Table 9 – Table 13, which report tissue matching 
results for each of the original EST libraries used and the relevant scaled down model 
data sets.  The initial and the final (reduced) number of total ESTs are shown and the 
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relevant correlation values are indicated for each pair.  Remarkably, the final mapped 
EST counts across all transcripts in each library which still yield positive intra-tissue 
correlation for the transcripts in the matrix are below 100 ESTs for all but 3 libraries 
tested and are below 10 total ESTs for 15 out of 33 libraries tested. 
 
As Figure 19 shows, a clear positive correlation exists for all five tissues between the 
size of the library and the quality of the match, with positive correlations ranging 
between 0.22 and 0.96.  This shows that library size has an impact on the quality of a 
library because a small library is less likely to be representative of expression in the 
original sample.  Despite this, the model scaled down libraries all presented a good 
tissue match, albeit with reduced correlation values.  This is summarised in Figure 20, 
where there is still positive correlation between size and the quality of the match for the 
scaled down libraries as well as for the original libraries, even though the values are 
reduced to between 0.15 and 0.88. 
 
Therefore, the quality of tissue typing does not change dramatically and for lung the 
correlations actually improved as the total EST counts were reduced.  These findings 
show that the matrix can be used to confirm the tissue identity of very small libraries, 
making it a very robust method for the quality control of expression libraries and tissue 
typing. 
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93 
Figure 10. Correlation of the EST matrix with individual libraries from matching 
tissues showing no inter-tissue correlation.  Pearson product-moment correlation 
coefficients (vertical axes) calculated for each of the individual EST libraries and the 
EST expression matrix.  A:  Placental libraries.  B: Lung libraries.  C: Pancreatic 
libraries.  D: Retinal libraries.  E: Testis libraries. 
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Figure 11. Correlation of the EST expression matrix with tissues with one or two 
libraries were available.  Pearson product-moment correlation coefficients (vertical 
axes) calculated for each of the individual EST libraries and the EST expression 
matrix).  A: "Soares_pineal_gland_N3HPG" library (dark bars), "Pineal gland II" 
(lighter bars).  B: "Small intestine I" EST library.  C: "NCI_CGAP_Br7" library from 
mammary gland.  D: "Thyroid" EST library. 
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Figure 12. Correlation of the EST expression matrix with individual EST libraries 
from related tissues.  Pearson product-moment correlation coefficients (vertical axes) 
calculated for each of the individual EST libraries and the EST expression matrix.  A:  
Brain EST libraries, these include one cerebellum and one cerebrum EST libraries. 
Assumed mixed tissue brain library showing positive correlation with pituitary gland is 
"NIH_MGC_181".  B: Peripheral nervous system libraries showing a degree of positive 
correlation with brain libraries.  C: Heart libraries showing a degree of positive 
correlation with muscle libraries.  D: Muscle libraries showing a degree of positive 
correlation with heart libraries. 
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Figure 13. Intra-tissue and inter-tissue correlations.  Correlation coefficients 
calculated for all of the 113 EST libraries against the EST expression matrix.  The data 
also include the tissues detailed previously in Figures 10 – 12.  A: Positive correlations 
between all expected matching libraries, e.g. all individual "Adipose" libraries vs. the 
"Adipose" expression matrix etc. Correlation value of "1" is for tissues where only one 
EST library was available.  B: Correlations for all expected non-matching libraries, e.g. 
all "Adipose" libraries available vs. all but the "Adipose" expression arrays from our 
EST matrix etc. The presumed mixed tissue brain library "NIH_MGC_181" was 
excluded from calculations.  C: Correlations for all expected related tissues, e.g. all 
individual "Brain" libraries available vs. the "Peripheral nervous system" expression 
matrix, etc.  D: All expected positive correlations from all matching libraries as in panel 
A (left box plot). Correlations from all related tissues as in panel B (middle box plot). 
All expected correlations from non-matching tissues, as in panel C (right). In all panels 
the boxes are drawn from the first to third quartiles. Plots also show minimum value, 
median (thick line) and the maximum correlation values recorded. 
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Figure 14.  Correlation of the EST matrix with individual libraries of reduced size 
from lung tissue.  Pearson product-moment coefficients (vertical axes) calculated for 
each individual EST library and the EST expression matrix.  A: Original libraries.  B: 
Reduced to 50% of original size.  C: 20% of original size.  D: Reduced to 10% of 
original counts.  E: Lowered to 5% of original size.  F: Lowered to 2% of original size.  
G: Reduced to 1% of original size.  H: Lowered to 0.5% of original size. The original 
sizes for each of the libraries used are listed in Table 9.
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Figure 15.  Correlation of the EST matrix with individual libraries of gradually 
reduced size from pancreas.  Pearson product-moment coefficients (vertical axes) 
calculated for each individual EST library and the EST expression matrix.  A: Original 
libraries.  B: Reduced to 50% of original size.  C: 20% of original size.  D: Reduced to 
10% of original counts.  E: Lowered to 5% of original size.  F: Lowered to 2% of 
original size.  G: Reduced to 1% of original size.  H: Reduced to 0.5% of original size.  
The original sizes for each of the libraries used are listed in Table 10. 
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Figure 16.  Correlation of the EST matrix with individual libraries of gradually 
reduced size from placenta.  Pearson product-moment coefficients (vertical axes) 
calculated for each individual EST library and the EST expression matrix.  A: Original 
libraries.  B: Reduced to 50% of original size.  C: 20% of original size.  D: Reduced to 
10% of original counts.  E: Lowered to 5% of original size.  F: Lowered to 2% of 
original size.  G: Reduced to 1% of original size.  H: Lowered to 0.5% of original size.  
The original sizes for each of the libraries used are listed in Table 11. 
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Figure 17.  Correlation of the EST matrix with individual libraries of gradually 
reduced size from retina.  Pearson product-moment coefficients (vertical axes) 
calculated for each individual EST library and the EST expression matrix.  A: Original 
libraries.  B: Reduced to 50% of original size.  C: 20% of original size.  D: Reduced to 
10% of original counts.  E: Lowered to 5% of original size.  F: Lowered to 2% of 
original size. G: Reduced to 1% of original size.  The original sizes for each of the 
libraries used are listed in Table 12. 
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Figure 18.  Correlation of the EST matrix with individual libraries of gradually 
reduced size from testis.  Pearson product-moment coefficients (vertical axes) 
calculated for each individual EST library and the EST expression matrix.  A: Original 
libraries.  B: Reduced to 50% of original size.  C: 20% of original size.  D: Reduced to 
10% of original counts.  E: Lowered to 5% of original size.  F: Lowered to 2% of 
original size.  G: Reduced to 1% of original size.  H: Lowered to 0.5% of original size.  
The original sizes for each of the libraries used are listed in Table 13. 
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Table 9. Library sizes and correlations for EST libraries from lung. 
Library Name Original 
library, 
the 
number 
of 
mapped1 
ESTs 
Positive 
correlation 
with the tissue 
of origin 
using EST 
expression 
matrices2 
Modelled 
scaled 
down 
library, the 
number of 
remaining 
ESTs3 
Positive 
correlation with 
the tissue of origin 
for the modelled 
scaled down 
library using the 
same matrices4 
Human Lung 536 0.40 461 0.48 
Stratagene lung 
(#937210) 
8,511 0.89 10 0.78 
Human adult lung 
3' directed 
MboICdna 
257 0.80 255 0.62 
Lung 401 0.85 6 0.76 
Fetal lung II 1,289 0.48 83 0.55 
NIH_MGC_77 12,494 0.95 11 0.88 
1 Mapped ESTs are the ESTs in each library which map onto transcripts. 
2 Using the matrices and as described at the beginning of this section. 
3 Each individual library was scaled down to model a smaller EST library and any fractional EST counts 
were rounded to the nearest whole number.  The reduced modelled EST counts below "0.5" were rounded 
down to "0". 
4 Gradual disappearance of low abundant ESTs resulted in the progressive change lowering in of the 
positive correlation with the tissue of origin and in many cases the eventual loss of that correlation.  Each 
library was scaled down until such positive correlation was lost.
111 
Table 10. Library sizes and correlations for EST libraries from pancreas. 
Library Name Original 
library, 
the 
number 
of 
mapped
1 ESTs 
Positive 
correlation 
with the tissue 
of origin using 
EST 
expression 
matrices2 
Modelled 
scaled 
down 
library, the 
number of 
remaining 
ESTs3 
Positive 
correlation with 
the tissue of origin 
for the modelled 
scaled down 
library using the 
same matrices4 
Human Pancreas 249 0.67 231 0.67 
Barstead pancreas 
HPLRB1 
709 0.81 4 0.39 
NCI_CGAP_Pan3 356 0.86 4 0.60 
NIH_MGC_78 557 0.82 2 0.46 
Pancreatic Islet 1,789 0.83 4 0.50 
1 Mapped ESTs are the ESTs in each library which map onto transcripts. 
2 Using the matrices and as described at the beginning of this section. 
3 Each individual library was scaled down to model a smaller EST library and any fractional EST counts 
were rounded to the nearest whole number.  The reduced modelled EST counts below "0.5" were rounded 
down to "0". 
4 Gradual disappearance of low abundant ESTs resulted in the progressive change lowering in of the 
positive correlation with the tissue of origin and in many cases the eventual loss of that correlation.  Each 
library was scaled down until such positive correlation was lost. 
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Table 11. Library sizes and correlations for EST libraries from placenta. 
Library Name Original 
library, 
the 
number 
of 
mapped
1 ESTs 
Positive 
correlation 
with the 
tissue of 
origin using 
EST 
expression 
matrices2 
Modelled 
scaled 
down 
library, the 
number of 
remaining 
ESTs3 
Positive 
correlation with 
the tissue of origin 
for the modelled 
scaled down 
library using the 
same matrices4 
Human Placenta 276 0.60 7 0.35 
Stratagene placenta 
(#937225) 
2,784 0.79 31 0.69 
Clontech human 
placenta polyA+ 
mRNA (#6518) 
705 0.45 34 0.35 
Soares_placenta_8t
o9weeks_2NbHP8t
o9W 
13,929 0.70 7 0.58 
Human placenta 
polyA+ (TFujiwara) 
405 0.53 13 0.42 
Human placenta 
cDNA (TFujiwara) 
1,367 0.66 24 0.35 
Placenta II 662 0.26 2 0.26 
Placenta I 1,168 0.33 11 0.15 
NIH_MGC_79 9,271 0.67 10 0.42 
NCI_CGAP_Pl1 1,856 0.74 2 0.50 
NCI_CGAP_Pl4 1,261 0.74 21 0.46 
Homo sapiens 
PLACENTA 
11,864 0.50 69 0.33 
1 Mapped ESTs are the ESTs in each library which map onto transcripts. 
2 Using the matrices and as described at the beginning of this section. 
3 Each individual library was scaled down to model a smaller EST library and any fractional EST counts 
were rounded to the nearest whole number.  The reduced modelled EST counts below "0.5" were rounded 
down to "0". 
4 Gradual disappearance of low abundant ESTs resulted in the progressive change lowering in of the 
positive correlation with the tissue of origin and in many cases the eventual loss of that correlation.  Each 
library was scaled down until such positive correlation was lost. 
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Table 12. Library sizes and correlations for EST libraries from retina. 
Library Name Original 
library, 
the 
number 
of 
mapped
1 ESTs 
Positive 
correlation 
with the 
tissue of 
origin using 
EST 
expression 
matrices2 
Modelled 
scaled 
down 
library, the 
number of 
remaining 
ESTs3 
Positive 
correlation with 
the tissue of origin 
for the modelled 
scaled down 
library using the 
same matrices4 
Soares retina 
N2b4HR 
9,160 0.91 13 0.54 
Soares retina 
N2b5HR 
1,722 0.62 7 0.24 
Human retina 
cDNATsp509I-
cleavedsublibrary 
706 0.64 4 0.49 
Human retina 
cDNA randomly 
primed sublibrary 
2,169 0.64 18 0.53 
Retina II 1,171 0.56 18 0.37 
1 Mapped ESTs are the ESTs in each library which map onto transcripts. 
2 Using the matrices and as described at the beginning of this section. 
3 Each individual library was scaled down to model a smaller EST library and any fractional EST counts 
were rounded to the nearest whole number.  The reduced modelled EST counts below "0.5" were rounded 
down to "0". 
4 Gradual disappearance of low abundant ESTs resulted in the progressive change lowering in of the 
positive correlation with the tissue of origin and in many cases the eventual loss of that correlation.  Each 
library was scaled down until such positive correlation was lost.
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Table 13. Library sizes and correlations for EST libraries from testis. 
Library Name Original 
library, 
the 
number 
of 
mapped
1 ESTs 
Positive 
correlation 
with the 
tissue of 
origin using 
EST 
expression 
matrices2 
Modelled 
scaled 
down 
library, the 
number of 
remaining 
ESTs3 
Positive 
correlation with 
the tissue of origin 
for the modelled 
scaled down 
library using the 
same matrices4 
TEST1, Human 
adult Testis tissue 
326 0.22 7 0.22 
Human Testis 293 0.48 4 0.22 
Testis I 1,525 0.56 1 0.47 
NIH_MGC_82 7,602 0.96 4 0.55 
NIH_MGC_180 4,984 0.44 17 0.22 
1 Mapped ESTs are the ESTs in each library which map onto transcripts. 
2 Using the matrices and as described at the beginning of this section. 
3 Each individual library was scaled down to model a smaller EST library and any fractional EST counts 
were rounded to the nearest whole number.  The reduced modelled EST counts below "0.5" were rounded 
down to "0". 
4 Gradual disappearance of low abundant ESTs resulted in the progressive change lowering in of the 
positive correlation with the tissue of origin and in many cases the eventual loss of that correlation.  Each 
library was scaled down until such positive correlation was lost. 
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Figure 19.  Pearson correlation values of original EST libraries (y-axis) vs. EST count (x-axis).  The black trendline is fitted to all of the data 
points shown (all tissues), while the other trendlines are fitted to the individual tissues: lung (dark blue), pancreas (pink), placenta (light blue), retina 
(yellow) and testis (brown). 
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Figure 20.  Pearson correlation values of original and scaled down libraries (y-axis vs. EST count (x-axis).  Data points corresponding to the 
original libraries, as shown in Figure 19 (blue).  Data points representing the modelled scaled down libraries, although the modelling involved non-
linear transformation of the data, the graph shows similar degree of positive correlation between 0.15 and 0.88 (pink).
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4.4.3. EST libraries from mixed, uncharacterised or poorly defined 
tissue preparations 
It was further decided to apply the EST expression matrix to the identification of 
unknown or mixed tissue libraries.  Small number of EST libraries annotated as being 
produced from uncharacterised tissues and therefore not included in the EST selection 
procedure, but for which their tissue origins are identifiable, were used.  Figure 21A 
shows correlation results for one such library (NCI_CGAP_HN5), derived from gum 
tissue.  This library shows clear positive correlation with the skin tissue type, which is 
the most related tissue type from the 26 tissue types included in the EST matrix, proving 
the accuracy of tissue typing using the matrix.  Another example of uncharacterised 
library is the umbilical cord library (Stratagene endothelial cell 937223) which showed 
positive correlation with vascular tissue type and to a lesser degree with ovary and 
peripheral nervous system tissue types (Figure 21B).  Whilst high positive correlation 
with vascular tissue and a degree of correlation with the ovary are likely, correlation 
with peripheral nervous system was unexpected because nervous fibres are only present 
in the proximal part of the umbilical cord (Marzioni et al, 2004).  However, since 
ovaries are innervated, the matching of both ovary and peripheral nervous system tissue 
types might be easily explained if the original preparation of umbilical cord contained 
some ovary tissue.  In the absence of further independent information on that library 
source it would be reasonable to assume that the tissue could have contained some 
ovary tissue or was obtained from the proximal part of the umbilical cord.  However, 
the highest positive correlation for this EST library is with vascular tissue which is the 
best match from the tissues available in the matrix.  These examples show that the EST 
expression matrix can help to identify tissue origins of EST libraries.  Figure 21C shows 
an example of correlations obtained for a pooled library (NIH_MGC_184).  The 
correlations indicate the presence of a mixed (lung + thymus) tissues.  Such a particular 
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tissue mixture is not impossible, since these two tissues are normally situated in very 
close proximity to each other and the library may indeed have been made from such a 
mixed tissue preparation (the library annotation is "pooled tissue").  Another example of 
mixed tissue library "NCI_CGAP_HN20" is shown in Figure 21D.  Correlations 
indicate the presence of ovary and thymus, the combination which is unlikely to have 
occurred by accidental tissue mixing, since the two organs are normally located far 
apart, but the library description does not specify the tissue origins and therefore no 
means exist to prove or disprove this tissue matching.  A conclusion from this particular 
result would be to avoid using such a library for quantitative expression analysis.  
Figure 21E and Figure 21F exemplify correlation values obtained for embryonic 
libraries ("Embryo, 8 week I" and "Embryo, 12 week II" respectively).  If these 
annotations are correct, and both libraries are made from the unfractionated embryonic 
tissue, the data would suggest that bone and brain tissue markers should have been more 
prominent at the earlier stages of development whilst towards week 12 muscle specific 
markers dominate.  Such changes do indeed reflect the high prominence of the brain 
over the rest of the embryo at early gestation stages and the forming of bone around 
weeks 5 and 10 of gestation (Brakus et al, 2010),  followed by the development of 
muscle tissues and heart at later developmental stages (Allan, 2010; Tanaka et al, 1995) 
thus validating the interpretation.  The stronger correlation with vascular tissue in the 
12-week library is consistent with increasing vascularisation following the development 
of the heart. 
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Figure 21. Correlation of the EST matrix with individual libraries from 
uncharacterised or poorly defined tissue preparations.  Pearson correlation 
coefficients (vertical axes) calculated between the individual EST libraries and the EST 
expression matrix.  A: "Uncharacterised" library NCI_CGAP_HN5 derived from gum 
tissue.  B: "Uncharacterised" Stratagene endothelial cell 937223 library.  C and D: 
pooled libraries NIH_MGC_184 and NCI_CGAP_HN20 respectively.  E: "Embryo, 8 
week I" library.  F: "Embryo, 12 week II" library. 
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4.4.4. EST libraries from cancer preparations 
Although initial cluster selection procedure relied on both normal and cancer libraries, 
about 95% of all the transcripts found were present in normal tissues.  The optimisation 
procedures relied on the normal EST libraries only.  It was therefore interesting to see 
how the EST matrix would score cancer library preparations, which are expected to 
reflect aberrations in gene expression as well as genomic abnormalities which 
characterise cancers.  Figure 22 shows a few typical examples of correlations obtained 
for a number of EST libraries from non-normalised bulk cancer tissues; these can be 
divided in two main categories.  The first group represent cancer libraries which 
correlate well with the stated tissues of origins (Figure 22A – Figure 22C).  One 
exception is a colon cancer library “NCI_CGAP_Co12”, where the "Gastrointestinal 
tract" EST profile scored nearly as well as the "Colon" profile.  This is likely because of 
the close relation between the two tissue type definitions (as Figure 11B shows, the 
gastrointestinal tract library is annotated as originating from the neighbouring small 
intestine) or because a mixed tissue preparation was used, or both.  The second group of 
libraries produced unexpected correlation results (Figure 22D – Figure 22F).  The tissue 
of origin did not score in any of these, and the matching, at least numerically, was with 
apparently irrelevant tissues (liver instead of brain in “NCI_CGAP_Brn64”, thymus 
instead of kidney in “NCI_CGAP_Kid13” and no single tissue scored in brain cancer 
library “NCI_CGAP_Brn53” (Figure 22F).  Clear tissue type matching in some cases of 
cancer derived libraries, but not in others is probably due to differences in cancer 
progression.  It is reasonable to expect that gene expression changes will increase with 
the progression of cancer and the progressive deregulation of normal cellular processes.  
The decreasing accuracy of tissue matching for cancer samples using the EST 
expression matrix is an indication that the analysis should be capable, in principle, of 
accurate cancer staging. 
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Figure 22. Correlation of the EST expression matrix with individual EST libraries 
from cancer preparations.  Pearson correlation coefficients (vertical axes) calculated 
between the individual EST libraries and the EST expression matrix.  A: Bone cancer 
library NCI_CGAP_Ch1.  B: Pancreatic library "Pancreas tumor III".  C: Colon cancer 
library NCI_CGAP_Co12.  D: Brain cancer library NCI_CGAP_Brn64.  E: Kidney 
cancer library NCI_CGAP_Kid13.  F: Brain cancer library NCI_CGAP_Brn53. 
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4.4.5. Normalised EST libraries 
Normalising a cDNA library changes the apparent expression levels in that library and 
should ultimately remove any differences in the gene expression (in normalised 
libraries) or leave only differentially expressed cDNA transcripts (in subtracted 
libraries).  The progressive disappearance of gene expression differences will depend on 
the degree of normalisation.  It might be reasonable to assume that unless the library is 
completely normalised the genes which were highly over expressed originally may still 
have high EST counts, albeit reduced to some degree.  For example if a hypothetical 
library containing three genes with relative abundances 1, 10, 100 is partially 
normalised to yield e.g. 11, 12 and 13 ESTs or e.g. 1, 2 and 3 ESTs, such three datasets 
would still correlate well with the original counts (for the above example the correlation 
would be +0.904 in both cases), and both such "normalised" libraries might both score 
reasonably well if correlated to EST expression matrix such as created in this work.  
Although normalisation and subtraction are in essence non-linear transformations we 
continued using Pearson product-moment correlation coefficient and did not calculate 
Spearman's and Kendall's correlation coefficients in order to keep the results 
comparable with all the previous calculations.  The correlation data for a number of 
normalised libraries are shown in Figure 23.  Normalised placenta library 
“NIH_MGC_148” correlated well with placental tissue array from the EST expression 
matrix scoring (+0.69) despite being normalised (Figure 23A).  Two different 
normalised lung libraries “UI-CF-EC1” and “UI-CF-FN0” both had lung as the most 
highly positively scored tissue, but had different levels of unanticipated cross-tissues 
correlation (Figure 23B and Figure 23C).  The data in Figure 23C show a degree of 
positive correlation with heart, muscle and spleen.  Such unexpected cross-tissue 
relations probably arise from gradual loss of lung gene expression specificity following 
normalisation.  This is clearly seen in Figure 23D, where normalised thymus library 
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“Soares_thymus_NHFTh” is scored using the EST matrix.  That library correlated with 
none of the 26 tissue types in our EST matrix. 
 
Using normalised libraries for the selection and optimisation the EST matrix was not 
feasible (with the degree of normalisation unknown no such optimisation was 
practically achievable).  Therefore, an alternative approach was used to validate the lack 
of tissue correlations found in normalised library such as in Figure 23D.  An artificial 
"normalised" EST matrix was created where all the 244 different transcript expression 
levels were set to "1" (except one value set to 0.999 to avoid a divide by zero error in 
calculating the Pearson correlation coefficient).  This model "normalised" dataset was 
then correlated to the EST expression matrix.  Similarly to the normalised thymus 
library “Soares_thymus_NHFTh”, the artificially "normalised" library did not correlate 
with any of the other tissues (Figure 23E).  Such lack of any correlation between the 
model "normalised" dataset and any of the tissues confirms that high degree of library 
normalisation will yield zero correlations if compared with the EST matrix.  To further 
test the robustness of the matrix another artificial dataset was created by assigning 
random values to each of the 244 transcripts.  Such an artificially arbitrary array did not 
show positive correlation with any of the 26 tissues from the EST expression matrix.  A 
representative graph is shown in Figure 23F.  Thus only tissue-specific non-normalised 
cDNA libraries (such as in Figures 10 – Figure 12) are expected and have yielded 
positive correlations, proving the functionality of the new approach. 
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Figure 23. Correlation of the EST expression matrix with individual EST libraries 
from cancer preparations.  Pearson correlation coefficients (vertical axes) calculated 
between the individual EST libraries and the EST expression matrix.  A: Bone cancer 
library NCI_CGAP_Ch1.   B: Pancreatic library "Pancreas tumor III".  C: Colon cancer 
library NCI_CGAP_Co12.  D: Brain cancer library NCI_CGAP_Brn64.  E: Kidney 
cancer library NCI_CGAP_Kid13.  F: Brain cancer library NCI_CGAP_Brn53. 
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5. Discussion 
5.1. Errors in CGAP tools and database, and solutions to these 
problems 
5.1.1. Errors in library search algorithm 
The existing CGAP library parsing algorithm used by CGAP until 12 May 2010 appears 
to search for libraries which contain the required tissue name in their "keywords" field 
regardless of whether that tissue name (a text string) is part of a longer phrase (part of a 
longer text string) such as "clear cell ovarian tumor" and regardless of whether their 
"unique tissue" field states a relevant or irrelevant tissue origin.  This resulted in a 
massively inaccurate choice of libraries and could easily lead to the selection of 
completely irrelevant libraries and yield artificial differences in gene expression and 
false disease markers.  This is a major problem, which went undetected for many years 
and which require re-evaluation of all previously reported results where NCBI CGAP 
expression data and tools were used.  CGAP creators allowed for the additional manual 
control of the choice of libraries before the gene expression data are obtained.  But even 
this feature might not be practical for larger library collections, such as e.g. brain (over 
1,000 libraries), or e.g. "uncharacterised tissue" (over 2,000 libraries, of which over half 
actually contain detailed descriptions with sufficient data for library classification). 
 
As Table 1 shows, the CGAP hierarchical classification system also appears to consider 
libraries made from secondary tumours which have formed by metastasis of the primary 
tumour in the tissue in question, as belonging to that tissue.  When brain tissue is 
selected, libraries are included from nine irrelevant tissues, including bone and bone 
marrow.  The bone library in question was created from a Ewing’s sarcoma sample.  Its 
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inclusion under brain tissue is erroneous because this is known to be a bone condition, 
although it has been discovered that Ewing’s sarcoma will metastasise to the right front 
parietal scalp, which is adjacent to the frontal and parietal lobes of the right cerebral 
hemisphere.  Generally speaking, when a secondary tumour forms it will present a 
significantly different gene expression profile from the primary tumour due to the 
different gene expression profile of the secondary tumour’s location.  Hence, for the 
purpose of gene expression analysis, secondary tumours should not be considered as 
belonging to the tissues they metastasised from.  Similarly, the inclusion of the bone 
marrow libraries under brain is erroneous because they are made from secondary 
metastases of the primary neuroblastoma, which is located in brain tissue (Ootsaka et al, 
2008; Yip et al, 2009). 
 
The suggested amendments implemented in our algorithm solve the problems by 
searching the contents of each library’s "unique tissue" field, with the result that our 
tool groups only the correct libraries to the chosen tissue type.  The effect of this is that 
any genes found to be differentially expressed between normal and cancerous libraries 
from that tissue will be genuine tumour markers because they are differentially 
expressed only in the specified tissue, and are not false positive results that are due to 
the impact of libraries from other tissues on the expression data, as could be the case 
with the CGAP results.  If those results are further investigated, these errors may give 
rise to incorrectly designed diagnostic tests or treatments. 
 
Once these findings were reported to NCBI by Andrew Milnthorpe on 12 May 2010 in a 
face-to-face discussion with Carl Schaefer at the US National Cancer Institute, this error 
in CGAP’s library parsing algorithm was corrected.  When last checked for this on 10 
January 2011, both xProfiler and DGED algorithms search for libraries which contain 
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the phrase for the chosen tissue in their “unique tissue” field and ignore libraries which 
contain this string as part of a longer string within this field.  However, as of 25 January 
2012, the CGAP parsing tools would still erroneously include libraries created from 
mixed tissue samples if their “keywords” annotations contain the required text phrase 
for the chosen tissue. 
 
Furthermore, CGAP’s parsing algorithms show an inconsistency in whether libraries 
from genuinely dependent tissues are presented in the results for their parent tissue and 
do not show bone marrow libraries under bone tissue.  The suggested amendments in 
our algorithm solve both of these problems through the availability of “pooled tissue” as 
a separate user-selectable tissue type instead of the inclusion of these libraries with 
tissues for which they contain one or more of the desired keywords, and the consistent 
presentation of libraries from dependent tissues in the results for their parent, if the user 
so-chooses (the recreated algorithm also gives the user control over whether dependent 
tissues are required). 
5.1.2. Errors in CGAP’s gene search algorithm 
The reasons were investigated as to why the list of cDNA xProfiler transcripts differ 
from the list obtained by DGED, as illustrated for adipose tissue in Figure 6.  The 
internally available flat file database accessed by the cDNA xProfiler was found to 
show differences in the transcripts present in each library when compared with the 
publicly available CGAP relational database.  It was not possible to find an explanation 
as to why this is so, given that not all transcripts which are reported by only one tool are 
related to those which are reported by both tools as shown in Table 14.  The analysis of 
transcript annotations revealed that the cDNA xProfiler incorrectly lists cDNAs which 
are absent from the library pool, but which have names or functions similar to the 
transcripts present in the designed library pool.  The effect of this is that, even if the list 
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of libraries for the chosen tissue is correct (as they are for tissues such as adipose, as 
Table 1 shows), the transcript list could still include false positive differentially 
expressed genes or omit valid tumour markers which could otherwise warrant further 
investigation for use in cancer diagnosis or as a novel target for anticancer therapy. 
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Table 14. Data from UniGene relational database for α-actinin transcripts reported by 
CGAP xProfiler and/or cDNA DGED tools for a comparison of a pool containing 
normal adipose libraries with a pool containing cancerous adipose libraries. 
Tool that reported 
transcript in either or both 
pools 
Symbol Title UniGene Cluster ID 
cDNA DGED only ACTN4 Actinin, alpha 4 270291 
cDNA DGED and  
cDNA xProfiler  
ACTN1 Actinin, alpha 1 509765 
133 
The recreated transcript parsing algorithms solve the problems associated with CGAP's 
cDNA xProfiler algorithm by reporting only the UniGene transcripts which ESTs in 
each library map on to, thus reporting the same transcript regardless of whether the 
output format is Boolean or includes the EST odds ratios, as Table 3 shows.  Now that 
the library parsing algorithm has also been corrected, this will ensure that the reported 
transcripts do not include false positive differentially expressed genes or omit genuine 
tumour markers which could otherwise be investigated further.  Since these findings 
were reported to NCBI on 12 May 2010 this error has been corrected.  Both tools (last 
accessed 10 January 2011) show identical numbers of genes when all the same 
parameters are used. 
 
However, as of 17 November 2011 the inclusion of certain libraries in a cDNA xProfiler 
search in which transcripts are reported in all columns of the results table (known 
unique, unknown unique, known non-unique and unknown non-unique) causes at least 
one non-unique transcript found in both pools which is non-unique to be incorrectly 
reported as unique in the rows representing both pools, despite the fact that the same 
transcript is correctly presented as non-unique in the list for each individual pool.  As 
Table 4 shows for brain this causes the number of transcripts in some boxes of cDNA 
xProfiler’s results table to be incorrect, with the correct numbers presented in Table 5. 
 
This suggests that the cDNA xProfiler is incorrectly processing the internally flat file 
database it accesses, in which the transcripts associated with each library are divided 
into known, unknown, unique and non-unique groups.  Although most of the problems 
had been corrected by 27 June 2012, some results continue to be incorrectly reported.  
This could lead to the discovery of false positive results or the omission of genuine 
candidate tumour biomarkers or targets from further study. 
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The Excel-based algorithm created in this investigation avoids this problem by 
searching the CGAP relational database instead, which does not report this information.  
However this algorithm can compare more than two pools in one search, so it is 
possible to ascertain whether a transcript is unique or non-unique to the chosen libraries 
by configuring an additional pool with every library except those in the other pools and 
elucidating which transcripts are also reported in that pool. 
5.1.3. Problem with CGAP statistics 
The statistics used by cDNA DGED are calculated using the Fisher Exact Test 
(Equation (1)) and the Benjamini-Hochberg False Discovery Rate (Equation (2)).  
Although the former does not depend on the display cut-off value for “F”, CGAP 
include “F” in the latter and therefore make the calculated false discovery rate “Q” 
value dependent on the display setting.  We believe this is an error, contributing to the 
false discovery rate of tumour markers or the omission of potentially valid markers. 
 
Although it was not possible to reproduce exactly the Benjamini-Hochberg 
implemented by cDNA DGED (Benjamini and Hochberg, 1995), the Fisher Exact Test 
was implemented, on which these statistics are supposedly based.  This approach is 
based on Equation (1) and it allowed the elucidation of where the observed expression 
difference of a given transcript between the two pools is due to chance.  The output is 
given on a scale of zero to one, such that “P” value close to zero for a transcript 
indicates that the observed expression difference for that transcript is not due to chance.  
As Table 6 shows, our method yields the same “P” values regardless of the chosen 
display cut-off values. 
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5.1.4. Problem with number of sequences reported and inclusion of 
empty or missing database entries 
The reason for the number of ESTs as annotated in the library database being greater 
than the ESTs of sequences which map onto the transcripts in the library was also 
studied.   This is illustrated for adipose tissue in Table 7.  This difference in the 
"sequences" annotation when compared to the "number of ESTs mapping onto 
transcripts in library" annotation could not explain the differences in the transcript lists 
produced by the CGAP tools and was thought to arise from the fact that some of the 
ESTs in the library did not map onto transcripts when the library was originally 
sequenced. 
 
Also, although the user can filter the libraries by size (by setting the minimum number 
of ESTs per library), the CGAP tools use the “sequences” annotation in the library 
database (see Figure 1) to implement such a cut-off, rather than the number of ESTs 
which map onto the transcripts in the library.  The CGAP approach produces results 
which are less reliable than they initially appear because, although the “sequences” 
annotation in the library database may be greater than the chosen cut-off value, the 
number of ESTs mapping onto the transcripts in the library may actually be below the 
cut-off. 
 
The actual number of ESTs which map onto a library’s transcripts was also calculated 
and the library parsing algorithm was programmed to apply the ESTs display cut-off to 
this value rather than the “sequences” annotation of each library, which includes ESTs 
which do not map onto transcripts.  As Table 1 shows this recreated algorithm reports 
the same total number of sequences in the library list as it does for the transcript list if 
the chosen output format shows the EST odds ratios, which in turn is the same as the 
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value reported by CGAP’s cDNA DGED for the same libraries.  The effect of this is 
that the user can more accurately apply this to determine the reliability of the reported 
libraries, for a library in which few ESTs map onto genes is less likely to provide a 
representative profile of gene expression in the sample from which it was created than a 
library in which many ESTs map onto transcripts.  Furthermore, the display cut-off will 
not take into account any ESTs which do not map onto transcripts, so it can be used 
reliably to determine the quality of the results. 
 
NCBI have not yet implemented a solution to this problem in the CGAP library and 
“gene” parsing algorithms (last checked on 12 January 2011).  The sum of the number 
of ESTs per library annotations (in the “sequences” field, as reported by CGAP’s library 
parsing algorithm) is still greater  than the number of ESTs the transcript parsing 
algorithm of cDNA DGED reports to be mapped onto all the transcripts in each pool at 
the top of the expression table.  Furthermore, it has also been discovered that the library 
named “SARS-Cov infected lung” is incorrectly annotated as containing no ESTs and 
the CGAP tools erroneously report this.  However, when the number of ESTs which 
map onto transcripts was calculated for all the libraries, this library was found to contain 
1,083 ESTs which mapped onto 1,023 transcripts.  This error could lead to the user 
deselecting this library due to its perceived non-contribution to the results, the 
consequences of which could be false positive discoveries or potentially valid tumour 
markers or targets not being further investigated.  The recreated algorithm solves this 
problem by presenting the number of ESTs mapping onto transcripts and using this for 
the ESTs display cut-off. 
 
The CGAP library database also appears to omit some of the libraries for which 
expression data is present in the expression database.  This could result in an inaccurate 
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choice of libraries for certain settings (however, it is impossible to know which 
combinations of settings this would apply to because of these libraries not being present 
in the library list).  As with the problems identified in CGAP’s library search algorithm, 
this could result in falsely discovered disease markers or the non-discovery of 
potentially genuine biomarkers or targets. 
 
Due to the lack of information available on these additional libraries it was not possible 
to enter them into the library database used by the recreated algorithm, so these libraries 
were therefore omitted from the expression database.  This has the advantage of 
increasing the number of searches that can be performed within a given time period. 
 
In addition to excluding libraries containing expression information as explained above, 
the CGAP library database also appears to include libraries which do not contain any 
transcript-mapping ESTs, as illustrated in Figure 7.  Similarly, the transcript database 
was found to contain transcripts which were not found to map onto any ESTs in any 
libraries, as Figure 8 shows. 
 
These are errors because the purpose of the database is for gene expression profiling and 
not to serve as a catalogue.  The libraries and transcripts concerned will not make any 
contribution to any results and will therefore not suggest any candidate biomarkers or 
targets for further investigation.  Furthermore, the number of libraries reported for a 
particular tissue can give an indication of tissue coverage (if more libraries are present 
for a tissue it is more likely that the results will be representative of in vivo expression 
levels), so the inclusion of empty libraries will mislead.  For this reason the number of 
transcript-mapping ESTs in those libraries must also be taken into account when 
assessing tissue coverage. 
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5.2. Further features of the created Excel-based tools 
5.2.1. Features included in Excel-based tools to address these 
shortcomings 
Two new algorithms have been created in Excel to mimic the capabilities of CGAP’s 
cDNA xProfiler and cDNA DGED tools.  In addition to solving the problems with the 
CGAP tools identified above, the new algorithms allow the user to compare three or 
more groups of samples to be compared side-by-side, a feature limited only by the size 
of an Excel worksheet, which permits a comparison of 8,192 groups of samples.  The 
new tools also allow mixed tissue libraries to be selected for inclusion in a pool 
separately from libraries from other tissues, unlike the CGAP tools which include them 
if one or more of the tissues listed in their “keywords” field is chosen, despite the fact 
that their gene expression levels are likely to be different from those in the chosen 
tissue. 
 
The new Excel-tools also make available lists of developmental stages, genders and 
pregnancy states that the user can choose to filter the list of reported libraries according 
to which of these they are annotated with.  This would enable results to be displayed 
which are solely caused by or a consequence of the cancer of interest, and not due to 
gene expression in the other situations detailed above. 
 
Finally, the new tools allow the user to choose whether the specified library name 
search string is used to present partial matches along with exact matches, or to report 
exact matches only.  This would avoid the problem of a library whose name is a partial 
match presenting a different expression profile and providing false positive results or 
leading to the omission of genuine candidate markers from the results. 
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5.2.2. Shortcomings of CGAP tools that are solved by the inclusion 
of the new features in the Excel-based tools 
Even if existing tools did not contain the errors detailed above, there would still be 
omissions made by the CGAP algorithms which are sorted with the inclusion of the 
features described above in the new Excel-based algorithms.  Currently the accepted 
gene expression profiling practice is to compare two groups of samples (EST libraries in 
the case of the CGAP tools) side-by-side (National Cancer Institute, n.d.e) (also 
reviewed in (Murray et al, 2007)).  However, there are situations where more than two 
pools would be useful, such as for studying the gene expression in tissues related or 
proximal to the tissue containing a tumour as well as the tissue to which the tumour is 
localised, at the same time as comparing that expression with the tumour and its tissue.  
This would reveal genes which are overexpressed in the tumour compared to all the 
chosen tissues, as well as enabling the separate study of those tissues.  Furthermore, one 
type of cancer could be studied separately from and compared with another in the same 
way.  For example, genes could be identified which are only expressed in papillary 
thyroid carcinoma and not in medullary thyroid carcinoma, thyroid or any related 
tissues (see Equation (7)). 
 
The existing CGAP tools do not allow libraries created from mixed or uncharacterised 
samples to be selected separately except those annotated as “uncharacterised tissue”.  
This could be useful, for example, in extending the quality control investigation by 
searching for expression data in such libraries and then comparing the values for the 244 
marker genes with those in the EST matrix, to determine if such libraries can, for 
example, be annotated with the correct tissue histology or library protocol. 
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The CGAP tools also do not enable the user to select which libraries should be 
displayed according to developmental stage, gender or pregnancy state.  This must be 
accomplished by selecting and deselecting libraries as appropriate once the list of 
matching libraries is presented.  Filtering the library list to present settings that the user 
desires would avoid genes being further investigated whose expression levels are due to 
the developmental stage, gender or pregnancy state of the individual rather than as a 
cause or consequence of the cancer. 
 
For example, selecting only adult libraries would mean that any observed expression of 
fibroblast growth factor signalling factors is due to the cancer of interest.  While 
overexpression of these proteins can lead to cancer, these proteins also play a major role 
in embryogenesis (Dailey et al, 2005).  Similarly, selecting just one gender will result in 
gene expression levels which are not dependent on gender, perhaps due to different 
lifestyles undertaken by each gender.  This would avoid the detection of KI-67, BLC-2 
and CD-44 if the focus is on non-small lung cancer in women, for these genes have 
been found to be more highly expressed in men.  While this has been thought to be due 
to the increased incidence of smoking amongst men (D’Amico et al, 2000), it has also 
been discovered that men have a higher risk of mortality even after smoking and 
treatment histories are taken into account (Visbal et al, 2004).  Filtering by gender 
would eliminate the risk of false positive results or the exclusion of genuine markers 
from further investigation due to differences in expression levels being due to different 
patients’ genders.  Furthermore, excluding libraries from pregnant individuals would 
ensure that observed overexpression of genes such as pregnancy-specific β1 
glycoprotein 9, which has been found to be overexpressed during the early stages of 
colorectal cancer (Salahshor et al, 2005), is a result of the cancer of interest and not due 
to libraries being included from pregnant individuals.  In a similar manner, cancers also 
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utilise the mechanisms which support pregnancy through the invasion of the uterus by 
the placenta and the evasion of the host immune system by the developing foetus 
(Holtan et al, 2009).  Therefore, not showing libraries from pregnant individuals would 
lead to results solely due to the development of the cancer. 
 
Finally, the CGAP tools at present will present partial matches for a library name search 
string.  However, two libraries which are from the same source but are named 
differently in this way may present different gene expression profiles.  For example, “a 
library named “Aorta endothelial cells” may present different expression information 
than one named “Aorta endothelial cells, TNF alpha-treated”.  In this case, it has 
previously been reported that platelet endothelial cell-adhesion molecule 1 (PECAM-1, 
CD31) expression significantly decreases when the endothelial cells are TNF-alpha 
treated (Stewart et al, 1996).  This is because along with interferon-γ, TNF-α induces 
the expression of many genes during the inflammatory response (Ohmori et al, 1997). 
5.3. Creation of a procedure for the quality control of gene 
expression data 
5.3.1. Optimisation of the list of tissue specific transcripts and 
creation of the EST expression matrix 
Along with the corrections to the errors in the CGAP tools and the implementation of 
improvements to those algorithms, the need was also identified for a quality control 
method for expression data based purely on the data itself. 
 
In the quest to create this method, the CGAP algorithms were used to select the initial 
list of 1,437 transcripts, which was subjected to two rounds of optimising to reduce 
inter-tissue correlations and improve intra-tissue correlations to produce a final list of 
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transcripts.  As a result, the 244 chosen transcripts are highly abundant in the tissue of 
interest when compared to all other tissues (high odds ratio), and present a high 
normalised EST count in the target tissue. 
 
An EST expression matrix of these markers in 26 tissues was created and used as the 
control against which other libraries were compared.  As mentioned earlier, tissue-
specific gene expression has previously been used as a quality control method to assess 
three SAGE databases (Huminiecki et al, 2003), but it has not previously been used as a 
quality control method within a single database. 
5.3.2. Tissue typing of EST libraries using EST expression matrix  
The EST expression matrix was correlated with 113 libraries of known identity.  The 
correlations presented in Figure 10 – Figure 12 show that the EST expression matrix is 
more versatile than had been anticipated, for it was not only possible to correctly 
confirm the tissue origin of the libraries presented, the matrix could also identify distant 
but related tissue types, as illustrated by Figure 12, which also proves that the matrix 
can identify possible contamination from tissues which are in close proximity to the one 
of interest.  Figure 13, which summarises all the correlations from Figures 10 – Figure 
12, shows that the inter-tissue correlations presented in Figure 12 were significantly 
greater than those between non-matching tissues.  Figure 13 also reveals that all the 
inter-tissue correlations were significantly smaller than the intra-tissue correlations. 
 
Further to this the matrix was correlated with small EST model libraries generated from 
the original libraries.  The findings presented in Figure 14 – Figure 18 and Table 9 – 
Table 13 show that the EST expression matrix is capable identifying the tissue of origin 
for expression libraries of different sizes containing between as little as ~ 1 EST counts 
(modelled scaled down library Testis I) and up to 13,929 EST counts 
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(Soares_placenta_8to9weeks_2NbHP8to9W).  This is despite a clear relationship 
between the size of a library and the quality of the tissue match, as presented in Figure 
19, and the positive intra-tissue correlations reported for the scaled down libraries were 
still significant, as reported in Figure 20.  These findings show that tissue-specific gene 
expression can be used as a robust quality control method because it can be used to 
correctly identify small libraries, which are likely to be less representative than large 
libraries due to the increased likelihood of only the more abundant transcripts being 
included. 
 
The results presented in Figure 21 further confirm the potential use of the EST 
expression matrix as a means to elucidate the tissue of origin of libraries whose tissue 
identity is unknown or not listed in the database record.  Six libraries were used whose 
tissue origins can be identified but which were not well characterised enough for 
selection and optimisation.  It was possible to identify the tissue origin of all six 
libraries, and in all but one case the identity matched the annotation, except for the 
pooled tissue library entitled “NIH_MGC_184”.  As Figure 21C shows, this library 
correlates best with lung and thymus, suggesting it was created from a mixture of these 
tissues, which are in close proximity to one another.  However, this library is annotated 
as originating from adrenal gland, parathyroid, thyroid and pineal gland.  Because all 
other libraries were correctly annotated (or, as with the other pooled tissue library 
entitled “NCI_CGAP_HN20 (Figure 21D), were not annotated in enough detail to be 
incorrectly labelled), this shows that the annotation of this library was incorrect.  This 
shows that the EST expression matrix can be used to identify incorrect annotations as 
well as verify the identity of correctly annotated libraries or characterise those which are 
not sufficiently annotated. 
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Cancer libraries were excluded from all but the initial cluster selection procedure, and 
around 95%of the transcripts detected were contained within libraries from normal 
tissues.  Cancer libraries were excluded from most of this work because they are known 
to show changes in gene expression as well as mutations to the genome (and therefore 
the transcriptome) which are characteristic of the type of cancer they were created from.  
As the disease progresses, gene expression in cancer is known to increasingly no longer 
resemble normal gene expression in the tissue in which the primary tumour arose.  As 
Figure 22 shows, six cancer libraries were compared with the EST matrix to elucidate 
its potential in cancer staging.  Figure 22A – Figure 22C present libraries which 
correlate well with the tissue with which they are annotated.  The exception is 
“NCI_CGAP_Co12”, which is shown in Figure 22C.  It is believed that the stronger 
correlation with colon than with gastrointestinal tract (as Figure 11B shows this is the 
adjacent small intestine) arose because these two tissues are closely related as part of the 
same organ system, or because the two tissues were pooled together during library 
preparation.  Figure 22D – Figure 22F show three libraries whose expression profiles 
did not match that of the stated tissue of origin.  It is though that this is due to these 
libraries being from later stages of cancer, in which the disease has metastasised to other 
tissues and the resulting secondary tumours present gene expression profiles resembling 
that of their new location.  This shows that the EST expression matrix can also be used 
for accurate cancer staging. 
 
Normalised libraries were not used in any of the methods used to prepare the EST 
expression matrix.  This is because the process of normalising a cDNA library alters the 
relative differences in transcript abundance levels.  The resemblance of the resulting 
gene expression profile to that in the state tissue of origin should depend on the extent 
to which the library has been normalised.  This was confirmed by the six libraries 
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presented in Figure 23which show different degrees of correlation with their annotated 
tissue of origin.  Figure 23A shows “NIH_MGC_148”, a placental library which still 
correlates highly with placenta, indicating a low degree of normalisation.  Figure 23B 
and Figure 23C present two lung libraries which increased correlation with other 
tissues, suggesting a greater degree of normalisation, the correlations arising from a 
gradual loss of gene expression matching that of the annotated tissue due to increased 
normalisation.  This is confirmed by Figure 23D, where “Soares_thymus_NHFTh” does 
not correlate with any of the tissues in the matrix, suggesting that this library is almost 
completely normalised.  This was confirmed through the creation of an artificial 
normalised library where all the expression levels were given an equal value of one, 
which, as Figure 23E shows, showed no correlation at all with any tissue.  Similarly, no 
positive correlation was presented by the artificial library of random values presented in 
Figure 23F.  These results show that it is possible to use the EST matrix to show the 
degree of normalisation of normalised libraries, for this is indicated by the degree of 
correlation with the annotated tissue of origin. 
5.3.3. Shortcomings of existing research the EST matrix has the 
potential to solve 
These findings show that tissue-specific gene expression can be used as a quality 
control method, an idea not examined by previous studies.  Other investigations 
focussed on the whole genome (Liang et al, 2006), studied aspects such as GC content 
(Arhondakis et al, 2006) or, even if they focussed on tissue-specific gene expression, as 
a few did (Russ and Futschik, 2010), did not use such data for quality control or 
evaluation purposes (Hu et al, 2000; Krief et al, 1999; Miner and Rajkovic, 2003; Pao et 
al, 2006; Vaes et al, 2002).  Furthermore, tissue-specific genes have been identified in 
this investigation which are also highly expressed in their target tissues, unlike the 
genes reported previously in (Li et al, 2011).This study is also an improvement on many 
146 
existing search tools and secondary database, including those hosted by CGAP, which 
are merely information repositories and retrieval algorithms with no numerical 
procedures for verifying the reported EST counts and the origins of the samples studied, 
both of which are assumed to be accurately reported (Elfilali et al, 2006; Strausberg et 
al, 2002; Zhang et al, 2004). 
 
This approach to the tissue-specificity problem is different from the previously reported 
attempts in that the origins of the expression data were looked into and the tissue 
specificity of the original preparations and the data quality were both assessed.  It was 
possible to generate a small optimised subset of 244 different transcripts which showed 
high levels of intra-tissue correlation between different EST libraries while presenting 
low levels of inter-tissue correlation, suggesting high tissue specificity.  The reported 
EST expression matrix can be used to confirm tissue identities of EST expression 
datasets for all main human tissue types, to provide insight into the origin of 
uncharacterised libraries, to identify normalised or subtracted libraries or various other 
experimental artefacts.  In a few cases it was possible to identify the location of the 
tumour from which a cancer sample was taken, an extension not previously considered 
and not previously reported.  Furthermore, this approach could be used to correctly 
identify very small libraries, which will have a lower depth of sequencing and will 
therefore not provide as good a quantitative estimate of gene expression than larger 
libraries (Simon et al, 2009) due to the reduced likelihood of rare transcripts being 
included (Bashir et at al, 2010).  The effect of library size has been included previously 
in statistical tests, which have been used to study gene expression levels in a range of 
cancers (Abba et al, 2004; Baggerly et al, 2003, 2004; Robinson and Smyth, 2007; 
Ruijter et al, 2002; Silveira et al, 2008; Thygesen, 2006), but this study is different from 
previous investigations in that its effect on inter-library correlations was studied.  
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Although the correlation with the original tissue was reduced, the scaled down libraries 
still presented an extremely good match for the tissue of origin, confirming the matrix 
as an extremely robust method of quality control. 
 
The next step is to adapt and apply this method to other publicly available gene 
expression data.  It is envisaged that with the increasing amounts of EST expression 
data, the optimised EST marker set could be improved and the tissue range might be 
expanded.  The use of other expression information, which could be obtained from 
SAGE data (Leyritz et al, 2008), DNA microarray data (Baron et al, 2011) and northern 
blots (Schlamp et al, 2008) and the merging of this data could improve the selection 
even further.  It is also envisaged that increasing amounts of available data could further 
decrease the number of transcripts in the expression matrix and may allow accurate 
analysis and tissue typing of the related and dependent tissues. 
148 
6. Conclusions 
CGAP’s cDNA xProfiler and cDNA DGED have been used by the scientific 
community to find genes which are differentially expressed in cancer for over ten years.  
It is known that such genes could be used as indicative biomarkers in diagnostic or 
prognostic tests or as therapeutic targets in novel treatments.  However, the currently 
accepted practice is to compare two pools of EST libraries, preventing the cancer and 
normal tissue in which the cancer is located from being compared with related or 
proximal tissues in the same search.  Providing 7 pools would enable genes which are 
preferentially expressed in the cancer compared to related or proximal tissues as well as 
the local tissue to be discovered and investigated much more efficiently than is currently 
possible. 
 
The provision of multiple pools makes a greater range of investigations possible in the 
same time frame.  However, everything depends on the algorithms themselves being 
correctly written.  The libraries reported must be the ones which originate from the 
specified tissue and the transcripts presented must be exactly those which are reported 
in the chosen libraries.  Furthermore, the statistics used must indicate the significance of 
differential expression between the two groups of libraries and not be dependent on the 
proportion of the results displayed.  Finally the data used must be archived and 
annotated correctly.  The CGAP algorithms and databases were found to contain 
significant errors which impact investigations carried out using those tools in all of 
these ways.  These problems have the potential to lead to incorrect diagnostic tests or 
treatments.  These sources of error would be eliminated by reconfiguring the database 
and recoding the tools in the ways suggested here. 
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Correction of the above problems would ensure that the results from investigations into 
differentially expressed genes in cancer would not be affected by errors in the 
algorithms.  However, the results are still dependent on the EST counts themselves 
being correct, which existing algorithms assume to be the case.  It has been shown here 
that the tissue type annotations of EST libraries could be verified by using an EST 
expression matrix based on tissue-specific markers, showing this method to be a 
suitable means of quality control.  Furthermore, the robustness of the new quality 
control method was confirmed by using it to correctly identity libraries which contain 
only a handful of ESTs.  Moreover, cancer staging can be performed by correlating the 
expression levels in a cancer library with those in the matrix to assess the degree of 
similarity with the stated tissue location of the tumour.  Another possible use of the 
matrix could be to indicate the amount of normalisation a library has undergone from its 
degree of resemblance to the tissue with which it is annotated. 
 
Together, these findings increase the reliability of the results of differential gene 
expression studies for cancer, eliminating the possibility of such errors leading to 
misdiagnosis of cancer patients and incorrectly applied therapy.
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